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Eukaryotic genomic DNA is packaged in the form of chromatin, which 
contains repeating nucleosomal units consisting of roughly  two super-helical 
turns of DNA wrapped around an octamer of core histone proteins composed of 
four histone species: one histone H3/H4 tetramer and two histone H2A/H2B 
dimers. Histones are basic globular proteins rich in lysine and arginine residues, 
with unstructured N-terminal “tail” regions protruding outside the nucleosome 
structure, and structured “core” domains in the DNA-associated portion. Several 
core residues, and in particular arginines in H3 and H4, mediate key interactions 
between the histone octamer and DNA in forming the nucleosomal particle. 
Histone post-translational modifications (PTMs) lead to downstream effects 
indirectly by allowing or preventing docking of effector molecules, or directly  by 
changing the intrinsic biophysical properties of local chromatin. To date, little has 
been done to study PTMs that lie outside of the unstructured tail domains of 
histones. I describe here the identification by mass spectrometry of a novel 
methylation site on histone H3, the asymmetric dimethylation of arginine 42 
(H3R42me2a). H3R42 is conserved through evolution and is at the DNA entry/
exit position within the nucleosome core, with likely interactions with the DNA 
backbone. I show that methyltransferases CARM1 and PRMT6 methylate this 
residue in vitro and in vivo. Using chemically-defined “designer” histones I also 
show that methylation of H3R42 stimulates transcription in vitro from 
chromatinized templates. Using peptide pull down experiments combined with 
enzymatic assays I demonstrate that H3R42me2a prevents the stimulation of the 
histone deacetylase activity of the N-CoR co-repressive complex by impeding its 
binding to H3.
Thus, H3R42 is a new histone methylation site with stimulating effects on 
transcription. I propose that methylation of basic histone residues at the DNA 
interface may be a general mechanism to disrupt histone:DNA interactions, with 
effects on downstream processes, including transcription.
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Chapter 1: Introduction
1.1 Chromatin is the physiological form of our genome
All organisms, prokaryotic or eukaryotic, must deal with the problem of 
packing a relatively  long piece of DNA into a small space within the cell. In 
eukaryotic mammalian cells, around two meters of genomic DNA are compacted 
over 10,000-fold to be packaged into a nuclear structure called chromatin (Allis et 
al., 2007), which was first identified and named by Walther Flemming in 1882 
because of its refractory nature and affinity  for dyes that preferentially stain basic 
residues (Flemming, 1882). The primary proteins that mediate the folding of DNA 
into chromatin are the histones, a series of acid-soluble proteins that were first 
isolated and characterized by Albrecht Kossel in 1884 (Kossel, 1911). 
Histones achieve DNA compaction through the assembly of repeating units 
called nucleosomes. In each nucleosome, 146 base pairs (bp) of DNA wrap 1.65 
times around an octamer formed by the four core histone proteins: an H3-H4 
tetramer and two H2A-H2B dimers (Kornberg, 1974; Kornberg and Thomas, 
1974; Luger et al., 1997). This array of repeating units is further compacted into 
more complex fibers, a process regulated by modifications of the histones 
themselves, linker histone H1 association, and the recruitment of structural 
proteins (Hansen, 2002) (Figure 1.1). 
All core histones within a given family are remarkably conserved in protein 
length and amino acid sequence through evolution (Allis et al., 2007; Van Holde, 
1989), and contain relatively  large amounts of lysine and arginine (over 20% of 
total number of amino acids). Histones H2A and H2B are lysine-rich (14 out of 
1
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Figure 1.1: The organization of chromatin
A) Schematic illustration of chromatin fiber condensation.  Adapted from 
(Hansen, 2002). B) Surface rendition of the nucleosome structure (PDB code 
1KX5). DNA is colored in gray, H2A, H2B, H3 and H4 are colored in yellow, red, 
blue and green, respectively.
129, and 20 out of 126 amino acids, respectively, in humans), while histones H3 
and H4 contain more arginine (18 out of 135, and 14 out of 102 amino acids, 
respectively, in humans) (Table 1.1). All four histones contain a globular histone 
fold domain at the carboxyl (C-) terminal end that mediates histone-histone and 
histone-DNA interactions, and charged tails at the amino (N-) terminal end which 
contain the bulk of lysine residues (Arents et al., 1991; Luger et al., 1997) 
(Figure 1.2).
1.2 DNA-Histone interactions are key for nucleosome stability
Even when compacted in the form of chromatin, DNA must remain accessible 
to the molecular machineries that execute critical DNA-templated processes like 
replication, transcription or repair. As a consequence, chromatin is a very 
dynamic structure. The key to understanding this dynamic nature lies in the 
structure of the nucleosome core particle itself, and in particular in the interaction 
between DNA and histones.
3
Table 1.1: Lysine and arginine content in human histones
Modified from (Van Holde, 1989).
Histones are bound to the DNA by noncovalent forces: the majority of 
interactions appear to be electrostatic since histones can be removed from DNA 
by high salt concentrations (Van Holde, 1989). Histones H2A and H2B dissociate 
first as the salt concentration is raised, followed by arginine-rich histones H3 and 
H4 (Burton et al., 1978). Zama and colleagues showed that the electrostatic 
interactions between the phosphodiester backbone of DNA and arginine residues 
present in the histone octamer are the most important for organizing DNA in the 
nucleosome (Ichimura et al., 1982). This major role of arginines is due to their 
capacity to form both hydrogen bonds and electrostatic interactions with 
phosphate residues along the DNA backbone.
Following the seminal work of Karolin Luger, Tim Richmond and colleagues, 
who solved the crystal structure of recombinant nucleosomes (Luger et al., 1997) 
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Figure 1.2: Core histone sequences
The amino acid sequences of the human core histones are shown. Arginines 
are highlighted in pink, and lysines are highlighted in light blue. Arrows 
designate arginine side-chains that are inserted into the DNA minor grove. 
Structured core regions are underlined. Modified from (Luger et al., 1997).
(Figure 1.1), we now know in great detail how histones interact with each others 
and how the octamer they form interacts with DNA. Histone H2A forms a 
heterodimer with H2B, and H3 forms a heterodimer with H4. Two H3/H4 dimers 
join together to form a tetramer, which plays the central role in organizing the 
nucleosome. Two histone H2A/H2B dimers interact on either side of the tetramer 
and consequently with DNA towards the ends of the molecule as it wraps around 
the histone core. The conformation of histones in the nucleosome structure 
places several arginines so that their side-chains are inserted into the DNA minor 
groove at every turn of the double helix (Luger et al., 1997) (Figure 1.2) and 
creates a positively charged, arginine-rich grove on its surface that creates a 
ramp  onto which DNA is wrapped (Arents and Moudrianakis, 1993; Luger et al., 
1997) (Figure 1.3).
More recent biophysical studies provided a high-resolution quantitative map 
of histone-DNA interactions in a nucleosome (Hall et al., 2009). The interaction 
map  revealed that histone-DNA interactions within a nucleosome are not uniform: 
the strongest region of interactions is located at the dyad axis (Figure 1.1) and 
another two regions of strong interactions lie approximately ±40 bp from the 
dyad. Mutations in these regions are known to greatly destabilize the 
nucleosome (Fry  et al., 2006). Weaker interactions were measured in the regions 
where the DNA enters and exits (Figure 1.1). Despite the observed weakness, 
the interactions at the DNA entry and exit points have been shown to be 
fundamental in controlling nucleosomal DNA accessibility and overall 
nucleosome unwrapping (North et al., 2012; Somers and Owen-Hughes, 2009). 
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The work presented in this thesis was aimed at understanding how the post-
translational modification of one particular arginine residue in histone H3 at the 
DNA entry/exit region might affect the process of transcription.
1.3 Histone post-translational modification
The study of histone modifications began when Murray reported the 
identification of lysine methylation in calf thymus histones (Murray, 1964). We 
now know that many different post-translational modifications (PTMs) can be 
affixed to histones, such as methylation, acetylation, phosphorylation, 
6
Figure 1.3: Coincidence of basic residues and DNA path.
Surface rendition of the nucleosome structure (PDB code 1KX5). DNA is 
colored in red, and the histone octamer is colored in grey. Basic residues are 
colored in blue. Modified from (Arents and Moudrianakis, 1993)
ubiquitylation, citrullination, ADP-ribosylation, sumoylation, biotinylation and 
others (Kouzarides, 2007; Tan et al., 2011). The number of identified 
modifications and of enzymes responsible for installing or removing them 
continues to increase as more sensitive methods, such as mass spectrometry, 
are applied to histone proteins (Garcia et al., 2007b). These modifications are 
attached to specific residues and deposited at specific genomic locations, and it 
has been suggested that a given collection of PTMs on one or more histones can 
contribute to the creation of a “histone code” that modulates gene expression, 
regulates chromatin structure, and dictates cellular and epigenetic identities 
during development, therefore extending the information potential of the genetic 
code encoded in DNA alone (Jenuwein and Allis, 2001; Strahl and Allis, 2000; 
Turner, 2000). 
Histone PTMs can function either through a direct, in cis, mechanism, or 
through an effector-mediated, in trans, mechanism (Figure 1.4) (Allis et al., 
2007). Modifications that function in cis directly  alter the biophysical properties of 
chromatin; those that function in trans influence the recruitment or activity of non-
histone proteins on chromatin.
Histone lysine acetylation can be used as an example of histone PTM that 
can function in cis. Early work conducted by Vincent Allfrey  at The Rockefeller 
University  correlated for the first time histone acetylation and methylation with 
active transcription (Allfrey et al., 1964), although rigorous sites of modification 
had yet to be identified. Later work supported this notion, demonstrating that 
some transcriptional co-activators possess an acetyltransferase activity (Brownell 
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et al., 1996) and that some transcriptional co-repressors are histone 
deacetylases (Taunton et al., 1996). The DNA backbone is negatively charged 
and electrostatically  interacts with histones that are enriched in positively 
charged side-groups. Addition of one acetyl group  to the ε-amino group of lysine 
neutralizes its positive charge. It has been shown that histone tail acetylation 
antagonizes chromatin fiber compaction and results in a chromatin template that 
is more permissive to transcription (Tse et al., 1998). In addition, the positively 
8
Figure 1.4: Mechanisms of histone PTM function. 
A) Histone PTMs (colored stars) that result in chromatin with different 
physical properties function in cis. Covalent modifications that function in 
trans either stabilize (B) or inhibit (C) the binding of effector proteins on 
chromatin. (Adapted from Allis et al, 2007)
charged N-terminal of H4 interacts with an acidic patch on adjacent 
nucleosomes, and acetylation of a single lysine on the H4 tail (H4K16) is able to 
reduce chromatin compaction (Robinson et al., 2008; Shogren-Knaak et al., 
2006).
Lysine methylation is one of the better-studied examples of histone PTM that 
can function in trans. Although methylation of lysine residues does not perturb 
their charge, specialized protein domains (also known as “reader” modules) exist 
that interpret particular methylation states (mono-, di- or trimethyl) and particular 
methylation sites in histone tails (Taverna et al., 2007). Chromodomains were the 
first class of protein domains shown to be specifically recruited by methylated 
lysines: in landmark papers, several groups showed that the chromodomain-
mediated binding of Heterochromatin Protein 1 (HP1) to histone H3 methylated 
on lysine 9 (H3K9) was necessary for its proper localization and function 
(Bannister et al., 2001; Lachner et al., 2001). More recently, domains other than 
chromodomains capable of binding methyl marks on histone tails have been 
identified. They include WD40-repeats, PHD, Tudor, plant Agenet, PWWP, 
SWIRM, and MBT domains (Martin et al., 2006; Maurer-Stroh et al., 2003; Shi et 
al., 2006; Taverna et al., 2006; Wysocka et al., 2005; Wysocka et al., 2006).
PTMs can also prevent association with binding proteins (Figure 1.4C). For 
example, recent studies have demonstrated that asymmetric dimethylation of 
arginine 2 of histone H3 (H3R2me2a) is a repressive mark that is mutually 
exclusive with H3K4me2/me3 both in yeast and human cells (Guccione et al., 
2007; Hyllus et al., 2007; Iberg et al., 2007; Kirmizis et al., 2007). While 
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H3K4me3 is enriched in the promoter of expressed genes and absent from 
downstream sequences, H3R2me2a is highest on inactive promoters, but also 
enriched inside and at the 3’ end of genes regardless of expression levels 
(Guccione et al., 2007; Guccione et al., 2006). This distribution pattern is 
explained by the fact that H3 recognition by WDR5, a common subunit of the 
MLL family  of H3K4 methyltransferase complexes, is abolished by the presence 
of H3R2me2a in in vitro binding assays (Couture et al., 2006; Guccione et al., 
2007; Hyllus et al., 2007; Iberg et al., 2007).
Direct recruitment is not the only  mode of action of histone methylation. 
Allostery is, in fact, another mechanism that extends the repertoire of trans 
effects of histone PTMs. Recent studies have shown that the H3K27 
methyltransferase complex PRC2 specifically  binds to histone tails carrying 
H3K27me3 through its subunit EED, and that this binding leads to the allosteric 
activation of the methyltransferase activity  of the complex (Margueron et al., 
2009).
1.4 Histone arginine methylation by PRMTs and its 
consequences
Arginines in histones can be mono- or di-methylated, the latter either in a 
symmetric (me2s) or asymmetric form (me2a) (Bedford and Clarke, 2009). The 
enzymes that mediate arginine methylation have been characterized and belong 
to the Protein aRginine MethylTransferase (PRMT) family. Nine enzymes within 
this family share conserved signature amino acid motifs, and are able to transfer 
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a methyl group from a donor S-adenosylmethionine (SAM) to a guanidino 
nitrogen of an arginine (Figure 1.5). Methylated arginines come in three possible 
forms in histones: monomethylarginine (MMA), asymmetric dimethylarginine 
(ADMA), and symmetric dimethylarginine (SDMA). PRMTs are classified on the 
basis of what modification they can catalyze: both type I and type II PRMTs can 
form an MMA intermediate; type I enzymes (PRMT1, 2, 3, 4, 6 and 8) catalyze 
the production of ADMA, while type II enzymes (PRMT5 and 7) catalyze the 
11
Figure 1.5: Arginine methylation
Addition of methyl groups (shown in red) to guanidine nitrogens of arginine 
forms monomethylarginine (MMA), dimethylarginine —  symmetric (SDMA) 
and asymmetric (ADMA). Type-I and type-II protein arginine 
methyltransferase (PRMT) are the catalytic enzymes for arginine 
methylation. Modified from (Bedford and Clarke, 2009).
formation of SDMA. (Bedford and Clarke, 2009; Krause et al., 2007). PRMTs 
methylate many cellular proteins, and most have histones among their 
substrates. The best-known arginine methylation sites on histones include 
arginine 3 on histone H4 (H4R3) and arginine 2, 17 and 26 on histone H3 (H3 
R2, R17, R26) (Bernstein et al., 2007). 
Since methylation of arginines changes their shape and removes a potential 
hydrogen bond donor, but does not affect their positive charge, it has been 
proposed that the main mode of action of histone arginine methylation is via 
recruitment of effector proteins, similarly to the mode of action of lysine 
methylation. In addition to preventing the binding of effector proteins described in 
Section 1.3, methylated arginines in histones have been recently  shown to recruit 
the tudor domain protein TDRD3 (Yang et al., 2010). TDRD3 binds to both 
activating marks H3R17me2a and H4R3me2a, and this results in its recruitment 
to active promoters to exert its co-activator function (Yang et al., 2010).
Arginine residues can also be converted to citrulline by deimination catalyzed 
by enzymes called Peptidyl-Arginine Deiminases (PADs). Enzyme PAD4 targets 
several arginine residues on H3 and H4 including H3R17 and H4R3 (Cuthbert et 
al., 2004; Wang et al., 2004), and recruitment of PAD4 to promoters results in 
loss of H3R17me2a (Denis et al., 2009). Given the lack, to this day, of a 
confirmed arginine demethylase enzyme (Chang et al., 2007; Webby et al., 
2009), deimination is the only known mechanism to counteract arginine 
methylation.
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The experiments presented in this thesis demonstrate that methylation of 
H3R42 is carried out in vitro and in vivo by methyltransferases CARM1 and 
PRMT6, which I will now cover in greater detail:
1) CARM1
PRMT4, also referred to as CARM1, was identified by Stallcup and 
colleagues as a steroid receptor-interacting protein capable of enhancing 
transcriptional activation, and was the first histone methyltransferase to be 
reported (Chen et al., 1999). The same group also demonstrated functional 
synergy between histone acetylation and CARM1 activity (Koh et al., 2001). 
These findings were the first piece of evidence that arginine methylation affects 
transcription. CARM1 methylates histone H3 at R17 and R26 (Schurter et al., 
2001), as well as several transcriptional regulators (Lee and Stallcup, 2009). 
Work from the Roeder laboratory at The Rockefeller University showed that 
methylation of specific H3 arginines by CARM1, in cooperation with 
methyltransferase activity by PRMT1 and acetyltransferase activity by p300, is 
critical in bringing about robust p53-dependent transcription from chromatin 
templates (An et al., 2004). The critical role of CARM1 in transcriptional activation 
is reflected in its requirement during development: CARM1 knock-out mice die 
quickly  after birth (Yadav et al., 2003) as a result of improper development or 
proliferation of T cells, adipocytes, chondrocytes and pulmonary  epithelial cells 
(Ito et al., 2009; Kim et al., 2004; O'Brien et al., 2010; Yadav et al., 2008).
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2) PRMT6
PRMT6 was first characterized by Mark Bedford and colleagues as an 
arginine methyltransferase with automethylation activity and distinct substrate 
specificity from PRMT1 and CARM1 (Frankel et al., 2002). PRMT6 is the main 
methyltransferase for H3R2 and H2AR29 in mammalian cells (Guccione et al., 
2007; Hyllus et al., 2007; Iberg et al., 2007; Waldmann et al., 2011). As 
mentioned in the Section 1.3, H3R2me2a prevents the MLL1 complex from 
methylating H3K4, making it a repressive histone modification. Moreover, 
H3R2me2a also prevents binding of many effectors that recognize H3K4me3 
marks (Iberg et al., 2007; Vermeulen et al., 2007). Despite its initial identification 
as transcriptional repressor, it has been recently reported that PRMT6 might 
have a positive role in regulating the transcription of a subset of nuclear receptor 
target genes (Harrison et al., 2010). Consistently with its role in transcriptional 
regulation, PRMT6 activity has been reported to influence embryonic stem cell 
identity (Lee et al., 2012) as well as cell proliferation and senescence, by 
downregulating the expression of p53, p21 and p16 (Neault et al., 2012; Phalke 
et al., 2012; Stein et al., 2012). PRMT6-deficient mouse embryonic fibroblasts 
(MEFs) undergo premature senescence, while PRMT6 knockout mice show no 
abnormal phenotype (Neault et al., 2012).
1.5 Identification of new histone PTMs by mass spectrometry
The work presented in Chapter 2 of this thesis was aimed at identifying new 
methylation sites on human histones. Traditionally, the identification of histone 
14
PTMs has relied on two methods: 1) incorporation of radiolabeled isotopes 
followed by Edman degradation, or 2) the use of specific antibodies in 
immunoassays. 
The first method is limited as the Edman degradation protocol can only be 
used if the N-terminal amino acid has not been chemically modified: the N-termini 
of mammalian H2A and H4 are acetylated, and therefore not easily  sequenced 
(often referred to as “blocked” proteins). Moreover, Edman sequencing can 
typically  only extend to about 30 residues since the efficiency of every cycle is 
below 100%, therefore making it impossible to identify PTMs affecting residues 
located further internally using this method. Antibody-based methods overcome 
these problems but present others, such as cross-reactivity of antibodies with 
different sites on the same or on another protein, and susceptibility to epitope 
occlusion, a phenomenon observed when PTMs near the epitope sterically 
prevent antibody binding. Most importantly, antibody-based techniques require 
an a priori knowledge of what to probe for, and are therefore unsuitable for 
unbiased analyses.
Mass spectrometry (MS) has recently been used as an alternative method for 
the discovery and the quantitative and unbiased analysis of histone PTMs 
(Garcia et al., 2007b). After separation of the peptide mixture by reverse-phase 
high performance liquid chromatography (RP-HPLC), MS measures the mass-to-
charge (m/z) ratio of peptides based on their behavior in the gas phase of the 
mass spectrometer. Since peptide isomers have the same mass (e.g. ARTK vs. 
ATRK), a second fragmentation step, followed by  m/z measurement of the 
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fragments, provides unambiguous identification of the peptide sequence. This 
step is key when trying to identify  the precise localization of PTMs on specific 
residues. This process is achieved with tandem MS, where the instrument takes 
both a MS and MS/MS spectra containing the precursor ions and the 
fragmentation ions of a peptide, respectively. Fragmentation is obtained with 
collision-induced dissociation (CID), which results in cleavage of adjacent amino 
acids at the peptide bond (Bonaldi et al., 2004).
The use of MS methods has greatly  extended our knowledge of histone 
PTMs. Two of the first MS discoveries of novel histone PTMs were the findings of 
methylation on H4R3 (Strahl et al., 2001) and H3K79 (Ng et al., 2002; van 
Leeuwen et al., 2002). More recent improvements in methods and 
instrumentation have made it possible to identify several dozens of novel 
modifications in single studies (Tan et al., 2011; Zhang et al., 2003).
Garcia and colleagues recently  developed a method that allows for a 
quantitative assessment of the abundance of PTMs on core histones (Garcia et 
al., 2007a; Plazas-Mayorca et al., 2009). Their method is based on trypsin 
digestion of the histone sample to be analyzed after derivatization by  propionic 
anhydride (Figure 1.6). Trypsin only cleaves at the C-termini of arginine and 
lysine residues if they are unmodified and not followed by a proline residue (Ong 
et al., 2004). Since histones are arginine- and lysine-rich, trypsin digestion of 
histones would result in small peptides that are difficult to retain on RP-HPLC 
columns and analyze by MS. By treating histones with propionic anhydride 
before trypsin digestion, all free amine groups  —  including the N-termini of 
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Figure 1.6: Schematic depiction of MS method for histone PTM quantification
Histones are propionylated to modify all the lysines in the sequence, therefore 
preventing cleavage by trypsin. Trypsinization results in cleavage at the C-termini of 
arginines. Another propionylation step  modifies the free N-terminus. The figure shows 
a partial sequence of human histone H3, with detail on the tryptic peptide containing 
R42. Unmodified and modified (me2 in orange) peptides of the same sequence have 
different MS peaks because of their different masses. Cleavage does not occur C-
terminal of R42 even when unmodified because R42 is followed by a proline. The 
relative amount of a peptide is estimated from the area under the curve (A.U.C.) for 
each peak.
peptides and ε-amino groups of unmodified and monomethylated lysine residues  
— are converted to propionyl amides. Therefore, trypsin digestion only induces 
proteolysis at the C-termini of arginine residues, unless these are methylated 
(Baldwin and Carnegie, 1971). Methylation of arginines, unless they are followed 
by prolines, generates a missed cut and a longer peptide. In addition, 
propionylation also reduces charges on treated peptides, which renders the 
histone peptides less hydrophilic. A further treatment with propionic anhydride is 
added after trypsinization. The resulting histone peptides can easily  be resolved 
by RP-HPLC, resulting in MS spectra that are easy to interpret. The produced 
peptides are approximately the same length and their masses can be predicted. 
Therefore, PTMs within a certain sequence can easily be identified because of 
predictable mass shifts. Since peptides of similar length behave similarly  in the 
gas phase, the relative abundance of unmodified and modified peptides can be 
quantified by comparing the areas under their MS peaks (Figure 1.6).
Using this method, Garcia and colleagues quantified several PTMs on 
histones (Dr. Benjamin Garcia, unpublished results). For example, acetylation of 
lysines in H3 and H4 is quite abundant, ranging from 5% to 30% depending on 
the site and cell type. Abundance of methylations on histone lysines is very 
variable depending on the site and cell type: H3K4me3 is in the 0.1-0.3% range; 
H3K27me3 is about 5-10%; H3K9 is trimethylated in about 15-20% of histones; 
about 70% of H4 is dimethylated on K20. Arginine methylation on histones is in 
general more rare and much closer to the detection limit of MS, which is about 
0.01% for a PTM. For example, H4R3me1 is less than 0.1%. This might explain 
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why fewer methylated arginines than other types of modified residues have been 
identified and studied on histones.
1.6 Use of designer histones to  study the function of specific 
PTMs
The main objective of the work presented in this thesis was to determine the 
direct effect of the methylation of a core residue in histone H3 on the process of 
transcription. For this aim, I took advantage of a technique called Expressed 
Protein Ligation (EPL) to generate homogeneously modified H3 proteins and 
used them in in vitro transcription assays. Traditionally, enzymatically-modified 
histones have been used in in vitro assays to measure the direct effects of the 
modification(s). For example, Roeder and colleagues showed that specific 
lysines, presumed targets of acetylation, and methylation of specific arginines in 
the N-tails of H3 and H4, catalyzed by the co-activators p300, CARM1 and 
PRMT1, are critical in bringing about robust transcription from chromatin 
templates (An et al., 2004). The authors assembled chromatin templates with 
wild type histones, or histones mutated on residues that are targeted by the co-
activators, and compared their transcriptional output. This method allows for the 
quantification of the contribution of the PTMs themselves. 
Mutations to alanine are frequently used because of the non-bulky and 
chemically inert nature of the residue. Some substitutions are engineered to 
minimize their structural effects: arginines are mutated to lysines and vice-versa, 
in order to maintain the basic character but abolish the modification potential. In 
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other cases, mutations that mimic a modified state are introduced: for example, 
glutamine is frequently used as an acetyl-lysine mimic. This method is highly 
effective but comes with several drawbacks: 1) histone modifying enzymes can 
target several residues at the same time, which makes it hard to study PTMs in 
isolation; 2) the efficiency of enzymatic modification varies by enzyme and 
experimental condition, making it impractical to compare effects of PTMs 
catalyzed by different enzymes; 3) the level of enzymatic modification of histones 
might not be high enough to result in a measurable effect on in vitro assays; 4) 
histone modifying enzymes could modify other proteins present in the assay mix 
and in turn affect their activity; 5) mutation of residues in histones might have 
direct effects on template properties that could affect the result of the in vitro 
assay used.
The use of EPL to generate designer histones makes it possible to overcome 
many of these problems (Allis and Muir, 2011; Chatterjee and Muir, 2010). EPL is 
a technique used to generate full-length proteins from synthetic peptides and 
expressed protein fragments. The synthetic peptides can include amino acids 
that are not directly incorporated via the genetic code, therefore permitting the 
incorporation of any histone modification of interest (Shogren-Knaak and 
Peterson, 2004). Most importantly, unlike enzymatically-modified histones, EPL 
provides homogeneously modified histones that can be assembled into 
nucleosomes and used in in vitro assays, bypassing the need for histone 
modifying enzymes. On the other hand, the disadvantage of this technique is 
that, since designer histones are homogeneously modified, the resulting 
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chromatin is also fully modified, a situation that does not reflect faithfully the 
situation observed in vivo, where histone PTMs are deposited at discrete 
positions. For example, this technique has been successfully used to 
demonstrate that acetylation on a single residue of H4 (Shogren-Knaak et al., 
2006), or ubiquitylation of H2B (Fierz et al., 2011), prevent chromatin compaction. 
1.7 Histone PTMs embedded in the nucleosome core
For nearly  four decades, the study of histone modifications focused 
exclusively on those that occurred on the tail domains of the core histones. The 
main reason tail PTMs dominated the field is that the primary method for 
discovering histone modifications, Edman degradation, favored the analysis of 
the first 20-30 amino acids. Things changed in 2002, when the application of 
mass spectrometry to the study of histone modifications allowed for the discovery 
of the first novel site of histone modification outside of the tail, methylation of 
histone H3 lysine 79 (Ng et al., 2002; van Leeuwen et al., 2002).
Histone core PTMs have unique effects on chromatin function. They fall into 
three distinct classes listed and detailed below: 
1) PTMs on the solute accessible face of the nucleosome
Tail modifications primarily act through trans mechanisms mediated by 
effector proteins. Some tail modifications, like acetylation or phosphorylation, can 
alter the charge of the tail and influence chromatin through electrostatic 
mechanisms. Similarly to what is observed with histone tail PTMs, modifications 
located on the solute accessible face of the nucleosome have the ability to alter 
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higher order chromatin structure and chromatin-effector interactions. Histone 
H3K79 methylation is the best-characterized modification on the nucleosome 
face (Figure 1.7). This modification, mediated by methyltransferase Dot1, was 
shown to prevent the binding of telomeric heterochromatin protein Sir3 to 
chromatin (Altaf et al., 2007), contributing to loss of telomeric heterochromatin 
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Figure 1.7: Some notable residues in the nucleosome core.
Surface rendition of the nucleosome structure (PDB code 1KX5). Octamer is 
colored in gray and DNA is colored in blue. Core residues that are mentioned in 
Section 1.7 are highlighted in purple. Surface arginines that have been shown to 
be methylated are highlighted in orange, H3R42 is highlighted in green. 
(Ng et al., 2002; van Leeuwen et al., 2002). In higher eukaryotes, H3K79 
methylation is also linked to transcriptional regulation and is enriched in the 
coding region of actively transcribed genes (Kouskouti and Talianidis, 2005), 
although the mechanism through which this PTM might affect transcriptional 
elongation is still unclear.
2) PTMs on the octamer lateral surface
Cosgrove and colleagues hypothesized in 2004 that covalent modifications on 
the nucleosome lateral surface could affect histone:DNA interactions (Cosgrove 
et al., 2004). This hypothesis led them to suggest a ‘regulated nucleosome 
mobility’ model, in which lateral surface PTMs lead to changes in histone:DNA 
affinity, which then result in more mobile nucleosomes. Mobile nucleosomes 
could be more readily displaced by proteins that must access DNA for processes 
like transcription, replication, etc. 
The direct effects of lateral surface PTMs on nucleosome stability have been 
demonstrated in several cases. For example, H3K56  is located in the DNA entry/
exit region (Figure 1.7): acetylation of this residue lowers octamer binding affinity 
to DNA (Andrews et al., 2010), increases DNA unwrapping (Neumann et al., 
2009), and enhances transcription factor binding within the nucleosome (Shimko 
et al., 2011). H3K56ac is essential for DNA replication (Xu et al., 2005), repair 
(Chen et al., 2008), and transcriptional activation (Williams et al., 2008). Another 
example is the acetylation of H3K122, a residue located at the dyad axis of the 
nucleosome (Figure 1.7), where histone-DNA binding reaches its maximum 
strength (see Section 1.2). H3K122ac can enhance the  rate of nucleosome 
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disassembly upon mechanical stress (Simon et al., 2011) and stimulate 
transcription and histone eviction (Tropberger et al., 2013).
The importance of residues on the lateral surface in controlling nucleosome 
stability and mobility has also been shown by  mutational analysis in S. 
cerevisiae. The amino acid substitutions H3-E105K, H3-R116H, H3-T118I, H4-
V43I and H4-R45H (Figure 1.7) were identified as SWI/SNF-independent (SIN) 
mutants, as they partially relieve the requirement for the chromatin remodeling 
factor SWI/SNF for the activation of some genes (Kruger et al., 1995). All these 
residues are on the lateral surface at the nucleosome dyad axis, and their 
mutation results  in decreased nucleosome stability and increased accessibility  of 
nucleosomal DNA (Kurumizaka and Wolffe, 1997; Wechser et al., 1997).
3) PTMs at the histone-histone interfaces
Modifications at the histone-histone interface have the ability  to disrupt intra-
nucleosomal interactions, thereby altering nucleosome stability. For example, 
H4K91 is closely juxtaposed and likely forms a salt bridge with a glutamate in 
histone H2B (Figure 1.7) (Cosgrove et al., 2004). Mutation of H4K91 to alanine 
(K91A) renders chromatin more sensitive to micrococcal nuclease digestion and 
makes H2A/H2B dimers easier to be displaced from chromatin by salt (Ye et al., 
2005). In addition, H4K91-acetylated histones co-purify with a histone deposition 
complex (Ye et al., 2005), suggesting a role for this PTM in modulating dimer-
tetramer interactions during chromatin assembly.
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1.8 Arginine 42 of histone H3
The work presented in this thesis was aimed at understanding how the post-
translational modification of one arginine of histone H3 on the nucleosome lateral 
surface affects the process of transcription. We were able to identify with 
confidence the novel asymmetric dimethylation of arginine 42 in histone H3 
(H3R42me2a), upon MS analysis of an antibody-enriched human histone sample 
(Chapter 2). H3R42 is at the entry/exit point of the DNA around the nucleosome 
(Figure 1.8A), and is a residue that is mostly conserved throughout evolution 
(Figure 1.8B). While most organisms contain an arginine at position 42 of H3, S. 
cerevisiae  carries a lysine, an amino-acid change with functional conservation. 
Both arginine and lysine are basic residues and have the potential to create 
electrostatic interactions or hydrogen bonds with DNA, suggesting that this 
contact is structurally important. 
I pursued the study of this particular residue for several reasons. First of all, 
the role of arginines situated within the globular domains of histones is still poorly 
understood, and in particular, if and how methylation in these domains might 
affect chromatin-templated processes remains unclear. Arginine residues are the 
most frequent hydrogen bond donors to backbone phosphate groups and to 
thymine, adenine, and guanine bases (Luscombe et al., 2001), and arginines in 
the core domains of H3 and H4 play essential roles in the folding of DNA into a 
nucleosome core particle (Ichimura et al., 1982). Intriguingly, addition of a methyl 
group to an arginine residue removes a potential hydrogen bond donor  and adds 
steric bulk, suggesting a possible role in controlling DNA:histone interactions. In 
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light of this, I hypothesized that methylation of H3R42 could be a mechanism 
used to modulate the interaction between DNA and the histone octamer.
Moreover, although several arginines on the DNA path in the nucleosome 
have been found to be methylated in large-scale proteomic studies (Cosgrove et 
al., 2004; Tan et al., 2011), no study to date has investigated the enzyme 
systems involved in depositing these modifications and their downstream effects. 
The previously identified methyl-arginines (H3R52, H3R53, H3R63, H4R35, 
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Figure 1.8: H3R42 in the nucleosome structure 
A) Cartoon rendering of the X.laevis nucleosome highlighting histone H3 Arg 42 
(circled dark blue spheres). Protein Data Bank ID: 1KX5. B) Sequence alignment 
of histone H3 from residue 34 to 52 from multiple eukaryotic species. The 
residue at position 42 is highlighted. 
H2AR42, H2AR77 and H2BR83) are highlighted in orange on the X. laevis 
nucleosome structure of Figure 1.7. While methylation of all these residues 
could, in theory, disrupt critical histone:DNA interactions, H3R42 (green in Figure 
1.7) appeared like a particularly  interesting candidate because of the potential to 
also be interpreted by reader modules. Compared to the other arginine residues, 
H3R42 comes more upstream on the DNA path around the octamer, and is 
therefore in a more accessible position for enzymatic modification and 
recognition by specific binders.
In addition, mutational studies have demonstrated that residue 42 in H3 is 
important in controlling nucleosome stability. Mutation of arginine 42 to alanine 
(R42A) makes nucleosomes more mobile and better substrates for nucleosome 
remodeling enzymes in vitro (Somers and Owen-Hughes, 2009). Boeke and co-
workers recently  showed in S. cerevisiae H3 that mutation of lysine 42 to alanine 
(K42A), but not to arginine (K42R), results in increased transcriptional output, 
and that H3K42 is methylated in vivo (Hyland et al., 2011).
For these reasons, I decided to focus my work on the novel methylation of 
H3R42, a PTM with the potential of having both indirect, effector-mediated 
consequences, and direct effects on nucleosome stability. The work presented in 
this thesis shows that H3R42me2a has indeed a dual role in promoting 
transcriptional activation, both directly by  affecting the biophysical properties of 
chromatin, and indirectly by protecting chromatin from histone deacetylation.   
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Chapter 2: Discovery of H3R42me2 and identification of 
enzymatic machinery
Although methylation of lysine residues in histones has been extensively 
studied, less attention has been paid to histone arginine methylation, in part 
because it is less abundant than its lysine counterparts (see Section 1.5). 
Despite its understudied status, arginine methylation is being increasingly 
appreciated as a critical epigenetic component in maintaining proper 
transcriptional regulation during organismal development (Chen et al., 1999; 
Phalke et al., 2012; Tee et al., 2010; Yadav et al., 2003). However, the 
biochemical mechanisms by which arginine methylation regulates transcription in 
a chromatin setting remains to be described in detail. For these reasons, I 
decided to focus on arginines, and in particular I sought to identify  and 
characterize novel arginine methylations on mammalian histones. 
 2.1 Discovery of H3R42me2
Arginine methylation is a rare PTM in histones, and most of the known 
methylations on arginines are at the limit of detection by mass spectrometry 
(0.05% to 0.1%: Dr. Benjamin Garcia, unpublished results). When histones are 
analyzed by MS/MS to identify methylated arginines, the overwhelming majority 
of peptides from the sample is unmodified, and modified peptides are rarely 
detected. To overcome this problem, I first decided to use an immunoprecipitation 
(IP) step in order to enrich for histones with methylated arginines. Upon this 
28
enrichment process, histones were subjected to MS/MS for identification of novel 
methylarginine marks. For the MS/MS analysis I established a collaboration with 
Gary LeRoy in the laboratory  of Benjamin A. Garcia, then at Princeton University, 
who did all the MS/MS analyses presented in this thesis.
Mathias Mann and co-workers have reported a method to identify novel 
arginine methylation sites on proteins based on enriching with antibodies 
targeted to methylated residues followed by liquid chromatography-tandem mass 
spectrometry analysis (Ong et al., 2004). The authors used commercially 
available antibodies recognizing proteins monomethylated and dimethylated on 
arginine residues (Abcam, product code ab412) to immunoprecipitate proteins 
extracted from HeLa cells. Subsequent analysis by tandem mass spectrometry 
allowed these workers to identify 59 novel methylation sites on several proteins. 
I chose to adapt their method for the discovery of methylarginine sites in 
chromatin-incorporated histones as outlined in Figure 2.1A. Histones from HeLa 
cells were extracted from a chromatin pellet derived from the classic Dignam and 
Roeder nuclear extraction protocol (Dignam et al., 1983). This step ensures that 
the PTMs observed are actually  incorporated into chromatin and not only present 
pre-deposition. The extracted histones were immunoprecipitated with ab412 
antibodies. After extensive washes, bound proteins were eluted and an aliquot 
was run on SDS-PAGE to check for recovery of histones after IP. Immunoblot 
with antibodies specific for H3R17me2a was performed as a control for 
enrichment of methylated arginines (ab412 could not be used for this control 
because in my hands it failed to function in western blots). Figure 2.1B confirms 
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that histones were successfully  immunoprecipitated, and enriched for methylated 
arginines.
The immunoprecipitated material was then propionylated, trypsinized and 
analysed by tandem mass spectrometry. Several previously known sites of 
arginine methylation were identified (H4R3, H3R17, H3R26: data not shown). 
One novel site of arginine methylation on histone H3 was identified: Figure 2.2 
shows the MS/MS spectrum  demonstrating the dimethylated tryptic peptide 
containing dimethylated arginine 42 (H3R42me2). No peptide corresponding to 
the mono-methylated form was detected. Since asymmetric and symmetric 
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Figure 2.1: Antibody-enrichment for histones with methylated arginines
(A) Schematic representation of the antibody-based enrichment method used to 
identify novel methylated arginines on human histones (B) Upon antibody-
enrichment, histones were run on SDS-PAGE side by side to 5% of the input 
material. Top  panel: Coomassie staining reveals the tipical banding pattern of 
histones. Bottom panel: the level of H3R17me2a was measured by western blot.
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Figure 2.2: MS discovery of H3R42me2
MS/MS spectrum of the 2+ charged precursor ion at 558.831 m/z 
corresponding to the propionylated/triptic dimethylated peptide (a.a. 41-49) Pr-
YRme2PGTVALR (Arg42 dimethylated) from histone H3. The sequence of the 
peptide containing is above; across the top are predicted b-type ions, which 
contain the amino terminus of the peptide, and across the bottom are predicted 
y-type ions, which contain the carboxyl terminus of the peptide. Those ions 
observed in the spectrum are underlined and indicated with an arrow. In the 
spectrum, the peaks corresponding to b ions are labeled in red and y ions in 
blue. Evidences for dimethylation of Arg42 are observed by the b2 ion at 404.3 
m/z and the y8 ion at 897.7 m/z.
dimethylated arginine have the same mass, and since the antibody used for 
enrichment is not specific for either of the two forms, it was not possible to 
identify the symmetry of dimethylation. 
 2.2 Screening for writers
In order to investigate, and ideally identify the methyltransferase(s) 
responsible for bringing about methylation of H3R42, I first purified human 
enzymes PRMT1-2-3-5-6-7-8-9 and CARM1 and tested each for its ability to 
methylate a histone H3 peptide centered on R42 (residues 34 to 52) Figure 
2.3A. Each enzyme was expressed as a Flag-HA tagged polypeptide in HEK293 
cells and immunoprecipitated with anti-HA resin to avoid carryover of 
endogenous PRMT5 due to its affinity for M2/anti-Flag resins (Nishioka and 
Reinberg, 2003). Methylation was visualized via transfer of tritiated methyl 
groups from the donor SAM. Since peptide lengths in the 15-20 residues range 
are reported as viable PRMT substrates (Guccione et al., 2007; Migliori et al., 
2012b), I chose to design a 19-mer centered around R42 where only three 
argines are present. I chose this length of peptides to minimize the number of 
other arginines present and at the same time leave enough residues so that an 
enzyme could recognize the sequence. On this first survey I chose less-stringent 
assay conditions (the in vitro methyltransferase reaction was incubated for 3 
hours at 30°C) in order to minimize the chance for false negatives. As shown in 
Figure 2.3B, under these assay conditions, CARM1 and PRMT6 were able to 
methylate the H3 peptide substrate, but none of the other tested enzymes were 
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able to do so. As a control, the enzyme panel was also tested against 
recombinant human histones with the same assay conditions, and all displayed 
some enzymatic activity, albeit to varying degrees (Figure 2.3C).
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Figure 2.3: CARM1 and PRMT6 methylate H3(34-52)
(A) Amino acid sequence of H3 peptide (34-52).  (B) H3(34-52) peptides or (C) 
ful l length recombinant human histones  were incubated with 
immunoprecipitated Flag-HA-tagged human PRMT1, 2, 3, 5, 6, 7, 8, 9 or 
CARM1 in the presence of 3H-methyl-SAM and resolved by SDS-PAGE. 
Radioactive methyl incorporation is quantified by fluorography. 
These initial results reduced the number of candidates to test from nine to two 
likely  candidates. One caveat of my work with short histone peptides is that the 
target residue can be one of three possible arginines in the substrate peptide 
sequence. As both CARM1 and PRMT6 are only  capable of dimethylating 
asymmetrically, it seemed likely that the dimethylation of R42 observed by  MS is 
asymmetric. 
 2.3 In vitro validation of writers
As the possibility  remained that the methylations carried out by CARM1 and 
PRMT6 in Figure 2.3 could be on arginine residues other than R42, I attempted 
to validate the site of methylation. Initial attempts to map the site of methylation 
by radioactive Edman degradation proved problematic because of the amino acid 
composition of the peptides used (data not shown). As an alternative I decided to 
use in vitro methyltransferase assays with peptide substrates. 
I first verified that CARM1 and PRMT6 can methylate histone H3 outside of 
the tail region. Since both CARM1 and PRMT6 have been shown to be active 
toward histones and peptides as a GST-tagged, single polypeptide purified from 
E. coli (Cheng et al., 2012), both enzymes were expressed and purified from 
bacteria. Radioactive methyltransferase assays were then carried out using as 
substrates either H3(34-52) peptides, full length recombinant human H3, or an 
H3 deletion mutant missing the first 28 amino acids (H3 ΔN28). The deletion 
mutant was designed so that it would be devoid of all the previously  known target 
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sites for CARM1 and PRMT6 (H3R2,R17,R26). I show in Figure 2.4 that both 
enzymes were able to methylate all three substrates.
To confirm methylation on the R42 residue I carried out radioactive 
methyltransferase assays with CARM1, PRMT6 and PRMT1 (as negative 
control) on H3(34-52) peptides harbouring unmodified, mono- or di-methylated 
R42. Comparison of the activity toward the unmodified and dimethylated peptides 
is a good way to estimate enzyme specificity for a site of interest, since the 
dimethylated peptide is a blocked substrate and can’t be further methylated on 
35
Figure 2.4: CARM1 and PRMT6 methylate non-tail residues of H3
Full length recombinant human H3, H3 ΔN28 or H3(34-52)  were incubated with 
GST-tagged human CARM1 or PRMT6 in the presence of 3H-methyl-SAM and 
resolved by SDS-PAGE. The top  panel shows the coomassie stain of the gel 
prior to being subjected to fluorography (bottom panel). Star indicates a 
radioactive band not corresponding to the substrate for the lane.
the target residue. The H3R42me1 peptide was added as a further test for 
specificity, since PRMT6 has been shown to add a methyl group to a mono-
methylated target more efficiently than an unmodified one (Hyllus et al., 2007; 
Lakowski and Frankel, 2008). Figure 2.5 shows the incorporation of radioactive 
methyl groups onto the different peptides: both CARM1 and PRMT6 methylate 
R42me1 peptides better than unmodified H3(34-52) ones, while neither can 
methylate R42me2a peptides, indicating specificity  for the R42 site. The higher 
activity  toward the mono-methylated substrate is also in agreement with our 
observation that no mono-methylated R42 was observed from MS analysis. No 
methylation was measured for PRMT1, although the enzyme was active as 
shown by the robust methylation observed on the H4(1-20) peptide containing 
the known substrate H4R3 (Bedford and Clarke, 2009). 
I also made sure that the conditions used for the enzymatic reactions just 
described (1 hour incubation and 1 μg of peptide substrate) were in the linear 
range for both enzymes. In the following titration experiments I kept both the 
amounts of purified enzyme (0.5 μg) and of radioactive SAM (1 μCi) constant, in 
keeping with standard published protocols (Cheng et al., 2012). I first performed 
time-course experiments using 1 μg of unmodified H3(34-52) peptide as a 
substrate and measuring the incorporated radioactivity at different time points. 
Figure 2.6 shows that the incorporated radioactivity increases linearly between 
30 minutes and 2 hours, validating the 1-hour reaction time used. Then I tested 
for dependance on substrate concentration using increasing amounts of 
unmodified H3(34-52) peptide. As shown in Figure 2.7, the incorporated 
36
37
Figure 2.5: CARM1 and PRMT6, but not PRMT1, methylate H3R42 in vitro
Results of in vitro methyltransferase assays for CARM1 (A), PRMT6 (B) or 
PRMT1 (C). The peptide substrates used are indicated at the bottom of the 
graph. Top  graph shows the levels (in cpm) of radioactive methyl incorporation 
for each peptide as measured by scintillation counting. The middle panel shows 
a representative fluorogram of the indicated substrates analyzed by 15% SDS-
PAGE. Bottom panel shows coomassie staining for the same substrates.
radioactivity increases linearly  between 0.5 and 2 μg of substrate, again 
validating the previously used reaction condition.
Since both CARM1 and PRMT6 were known to methylate the H3 N-tail on 
H3R17 and H3R2, respectively (Bedford and Clarke, 2009), I repeated the 
radioactive methyltransferase assays including as a point of reference the 
unmodifed H3(1-20) peptide that carries one target site for both enzymes (R17 
for CARM1 and R2 for PRMT6). As shown in Figure 2.8, CARM1 displays 
comparable activity toward unmodified H3(1-20) and H3(34-52) peptides, while 
PRMT6 higher activity toward H3(1-20). These results suggest that R42 might be 
a more physiological target for CARM1 and a secondary target for PRMT6.
Taken together, these initial results with histone peptides demonstrate that 
H3R42 is methylated in vitro by both CARM1 and PRMT6.
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Figure 2.6: Time-course analysis
The graphs show the amount of radioactivity incorporated on H3(34-52) 
peptides after incubation with CARM1 (A) or PRMT6 (B), as a function of 
reaction time. Radioactivity was measured by scintillation counting of P81-
absorbed reactions.
 2.4 In vivo validation of writers
To further test the CARM1/PRMT6-H3R42 hypothesis in vivo, I decided to see 
whether perturbations in the expression of CARM1 or PRMT6 would affect the 
levels of H3R42me2a. Despite several immunization attempts, we have not been 
able to obtain reliable and specific antibodies against H3R42me2a. Therefore, it 
is not possible to quantify easily the methylation levels with a simple western blot. 
One reliable way to quantify H3R42me2a is by using mass spectrometry and 
comparing the peak areas corresponding to the dimethylated and unmodified 
R42 peptides after propionylation and trypsin digestion (see Section ???). 
 To this end I performed siRNA knockdown of CARM1, PRMT6, or both, in 
HEK293 cells and acid extracted histones after 72 hours of siRNA treatment. 
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Figure 2.7: Substrate concentration analysis
The graphs show the amount of radioactivity incorporated on H3(34-52) 
peptides after incubation with CARM1 (A) or PRMT6 (B), as a function of 
substrate concentration. Radioactivity was measured by scintillation counting of 
P81-absorbed reactions.
H3R42me2 levels were determined by MS, relative to cells treated with control 
siRNA. As shown in Figure 2.9, the knockdown of CARM1 and PRMT6 was 
effective in reducing the abundance of both enzymes. CARM1 siRNA alone 
resulted in a slightly larger reduction of H3R42me2 compared to PRMT6 siRNA 
alone, which is in line with the previous results suggesting that R42 might be a 
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Figure 2.8: Comparison of activity toward H3R42 and previously known 
substrates
Comparison of methyltransferase activity against different peptide substrates 
between CARM1 and PRMT6. Activity  was measured by scintillation counting in 
triplicate experiments and is expressed as percentage of the activity  measured 
for H3(34-52) peptides. Baseline (0%) was set as the activity measured in no 
substrate controls (no peptide). 
more physiological target for CARM1 and a secondary target for PRMT6. The 
double knockdown resulted in almost undetectable levels of the mark. 
In addition, I tested whether overexpression of the enzymes would result in 
increased methylation of H3R42. For this I generated HEK293 cell lines stably 
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Figure 2.9: Knockdown of CARM1 and PRMT6 reduces H3R42me2a in vivo
Top  panel shows the levels of CARM1 and PRMT6 measured by western blot in 
HEK293 extracts after treatment with either control siRNA or siRNAs against 
CARM1, PRMT6, or both. H3 levels are shown as loading control. Bottom graph 
shows the levels of H3R42 methylation measured by MS in acid extracts from 
the same cells. The percentage of H3R42 methylation for each sample is 
expressed in fold changes relative to the siSCRAMBLE control sample. 
overexpressing CARM1 or PRMT6. The acid extracted histones were analysed 
by MS. Figure 2.10A shows that H3R42me2 levels increase significantly with 
overexpression of either enzyme, although overexpression of CARM1 resulted in 
a bigger effect than PRMT6, again validating the preferential of CARM1 for 
H3R42me2a in comparison to PRMT6. Finally, I took advantage of the existence 
of CARM1 -/- mouse embryonic fibroblasts (MEFs) (Yadav et al., 2003), and 
compared the levels of R42 methylation in acid extracted histones from CARM1 
+/+ and CARM1 -/- MEFs. Deletion of CARM1 results in marked decrease in 
H3R42me2 levels, further supporting a role in vivo for this enzyme in modifying 
H3R42 (Figure 2.10B).
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Figure 2.10: Perturbation in the levels of CARM1 and PRMT6 affects 
H3R42me2a in vivo
(A) Levels of H3R42me2 were measured by  MS in acid extracts from HEK293 
either untransfected (wt), or overexpressing CARM1 or PRMT6. The results are 
expressed in fold changes relative to the untransfected (wt) sample. (B) Levels 
of H3R42 methylation were measured by MS in acid extracts from CARM1(+/+) 
or CARM1(-/-) MEFs. The results are expressed in fold changes relative to the 
CARM1(+/+) sample.
Taken together these results demonstrate that CARM1 and PRMT6 methylate 
H3R42 in vivo, and that the two enzymes regulate the global level of 
H3R42me2a.
 2.5 Screening for H3R42 deimination
The level of most histone PTMs is maintained by an equilibrium between 
writer and  eraser enzymes (Allis et al., 2007). With the experiments presented in 
the previous sections of this chapter I identify two enzymes that methylate 
H3R42 in vivo and in vitro. 
As described in Section 1.4, deimination by PAD enzymes is the only known 
mechanism that can counteract arginine methylation (Chang et al., 2007; 
Cuthbert et al., 2004; Wang et al., 2004; Webby et al., 2009). I therefore decided 
to test whether deimination could be used to regulate the methylation levels of 
H3R42. 
Given the identification of CARM1 and PRMT6 as the methyltransferases 
responsible for H3R42 methylation, and since PAD4 has been shown to target for 
deimination residues that can be methylated by both PRMT6 and CARM1 (H3R2 
and R17, respectively) (Cuthbert et al., 2004), it seemed reasonable to test PAD4 
as a candidate for deiminating H3R42. 
Purified PAD4 was incubated with either H3(34-52), or H3(34-52)R42me2a 
(negative control: PAD4 cannot deiminate dimethylated residues), or full length 
human H3 (positive control). This in vitro citrullination reaction was subjected to 
western blot with anti-citrulline antibodies. PAD4 did not deiminate residues in the 
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region of H3 encompassing R42, while it was fully active against full length H3, 
suggesting that either other PAD enzymes or different mechanisms are involved 
in negatively regulating H3R42me2a (Figure 2.11).
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Figure 2.11: H3R42 is not a target for PAD4
Purified PAD4 was incubated with unmodified or dimethylated H3(34-52) peptides 
or full length H3 (positive control). Citrullination was detected by western blot.
Chapter 3. Direct effects of H3R42me2a on in vitro 
transcription
The results presented in the previous chapter support a novel role for 
methyltransferases CARM1 and PRMT6 in regulating the level of H3R42 
methylation, a site that differs from the other better-characterized sites of 
methylation in the H3 N-tail (R2, R17 and R26).  In this chapter I will describe 
experiments aimed at understanding the function of this novel PTM, and in 
particular its contribution to transcriptional activation.
3.1 Rationale for choosing to study H3R42me2a in the process 
of transcriptional activation
Several lines of evidence suggest that methylation of H3R42 might be 
involved in transcriptional regulation. 1) CARM1 is a well-characterized 
transcriptional co-activator (An et al., 2004; Chen et al., 1999), and PRMT6, 
albeit being initially  associated with transcriptional repression (Guccione et al., 
2007; Hyllus et al., 2007; Iberg et al., 2007; Kirmizis et al., 2007), has been more 
recently shown to be involved in activation of a subset of target genes (Harrison 
et al., 2010). 2) Mutational studies have implicated the importance of CARM1 
activity  on target arginines in H3 N-tail with direct stimulatory effects on in vitro 
transcription from chromatinized templates (An et al., 2004). 3) H3K42 in S. 
cerevisiae is methylated in vivo and mutation to alanine (K42A) results in 
increased transcriptional output (Hyland et al., 2011). 4) H3R42 is in a critical 
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position within the nucleosome (North et al., 2012; Somers and Owen-Hughes, 
2009) and it can hypothesized that methylation might disrupt critical protein-DNA 
contacts. For all these reasons, in my effort to understand the function of this 
novel histone PTM, I first asked whether H3R42me2a could have a direct effect 
on transcription.
It seemed clear that the best way to pinpoint the effect of a single PTM on 
transcriptional activation would be to study it with in vitro transcription assays on 
chromatinized templates. In 1979, the laboratory of Robert Roeder at The 
Rockefeller University reproduced, using a naked DNA template, the accurate 
transcription of an mRNA-encoding gene in a test tube (Weil et al., 1979). It was 
later discovered that chromatinization of the DNA template prevents 
transcriptional initiation (Lorch et al., 1987; Workman and Roeder, 1987). As a 
result, chromatin-based transcription systems have been developed that are able 
to simulate in vitro the barrier to transcriptional activation imposed by chromatin 
(An and Roeder, 2004).
 The system that was used for this thesis is based on assembling a chromatin 
template with purified assembly factors and recombinant histones (An and 
Roeder, 2004). The general assay scheme is shown in Figure 3.1A. The DNA 
template resembles the model in Figure 3.1B: activator binding sites upstream of 
a TATA box element are flanked by nucleosome positioning sequences to allow 
for precise nucleosomal deposition. Chromatinization of the template is obtained 
with the ATP-dependent ACF system introduced by Kadonaga and colleagues 
(Ito et al., 1999), which uses three recombinant proteins (Acf1, ISWI, and NAP1) 
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and generates a chromatin template with regularly spaced nucleosomes. The 
use of recombinant assembly factors rather than insect or frog extracts allows the 
use of recombinant octamers devoid of any modification. The transcription 
reaction is strictly dependent on addition of specific DNA binding activators, and 
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Figure 3.1: General procedure of in vitro transcription assays 
(A) Schematic summary of chromatin assembly, modification, and transcription 
protocol. The chromatin templates are assembled with recombinant octamers 
using NAP1 and ACF/ISWI assembling system. After DNA-binding activators 
are bound to the template, histone modifying coactivators are added with their 
respective cofactors. HeLa nuclear extracts provide the machinery for the 
transcription reaction, which starts after addition of NTPs (B) Schematic 
representation of the template used in transcription assays. Adapted from (An 
and Roeder, 2004). 
the transcription machinery is provided by addition of nuclear extract. A G-less 
cassette downstream of the core promoter allows direct analysis of the 
synthesized RNA by autoradiography. Since histones are of recombinant origin, 
mutant histones (or designer histones, see Section 1.6) can be used in 
conjunction with histone modifying cofactors to allow for functional analysis of 
specific histone modifications. Given the almost complete control on the 
experimental conditions, these assays are perfectly suited to quantify the effect 
of H3R42me2a on transcription.
I initially set out to expand on the work led by Woojin An, then a post-doctoral 
associate in the Roeder laboratory (An et al., 2004). This study showed that 
CARM1 stimulates p53-dependent transcription in vitro, and that the stimulatory 
effect of CARM1 is partially lost when H3R2, R17 and R26 are mutated to 
glutamine. Since I show that R42 is a target for CARM1, I decided to ask whether 
R42 mutation could impair CARM1-dependent transcriptional stimulation. I then 
took advantage of designer histones homogeneously dimethylated on H3R42. 
This set of experiments was made possible by the generous contributions of Dr. 
Xiangdong Lu in the Roeder laboratory at the Rockefeller University, who 
performed the transcription assays presented in this thesis, and Sam Pollock, an 
undergraduate student in the Muir laboratory at Princeton University, who 
synthesized the designer H3(R42me2a) molecule.
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3.2 CARM1 methylates R42 in nucleosomes
In Chapter 2 I have shown that CARM1 controls the level of R42 methylation 
in vivo, and that it methylates R42 on peptide substrates in vitro. Before 
performing transcription experiments on chromatinized templates, I needed to 
confirm that CARM1 could indeed methylate R42 in the context of the 
nucleosome. For this purpose I assembled octamer and mononucleosome 
substrates from recombinant human histones (Figure 3.2). Briefly, N-terminal 
6xHis-tagged histones were expressed in E. coli, extracted from inclusion bodies 
and purified by Ni-NTA affinity resin. Denatured, purified histones were combined 
in dialysis buttons such that H3 and H4 were slightly limiting and dialyzed into 
high salt buffer. TEV or PreScission proteases were used to remove the 6xHis 
tags. Untagged octamers were purified from unincorporated dimers, individual 
histones and proteases by Superdex 200 size exclusion chromatography. 
Fractions containing octamers were pooled and verified by SDS-PAGE.
Mononucleosomes were formed by combining purified octamers with 153 bp 
dsDNA corresponding to the 601 strong positioning sequence (Lowary  and 
Widom, 1998), followed by gradient dialysis from 2M NaCl to 0.1M NaCl over 
approximately  30 hours, as described in (Ruthenburg et al., 2011). Assemblies 
were checked for proper DNA incorporation by native 5% polyacrylamide gel 
electrophoresis and ethidium bromide staining (Figure 3.3).
Recombinant CARM1 was incubated with equal amounts of either 
recombinant octamers or mononucleosomes with SAM as a methyl-donor. One 
small aliquot of each reaction was incubated with radioactive SAM as a control 
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Figure 3.2: Assembly and purification of recombinant octamers 
Purified recombinant 6xHis tagged human histones were combined in 
denaturing buffer and dyalized into high salt buffer to assemble octamers. The 
tags used for purification were removed with TEV and PreScission proteases 
and octamers were further purified sith Superdex 200 size exclusion FPLC. The 
resulting chromatogram is shown, A280 absorbance graphed as a function of 
time. Octamer peak fractions were pooled as indicated (red box) and analyzed 
by SDS/PAGE and Coomassie staining 
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Figure 3.2
for methyltransferase activity and is shown in Figure 3.4A. The reaction products 
were analyzed by MS/MS for R42 methylation: H3R42me2a was detected from 
both the octamer and nucleosome reactions, although methylation of R42 in the 
nucleosome context was several folds less efficient than in octamer form (Figure 
3.4B). This difference in efficiency most likely reflects the barrier imposed by the 
DNA in the nucleosome structure. The apparent disconnect between the 
incorporated radioactivity in Figure 3.4A and the levels of H3R42 methylation of 
Figure 3.4B can be explained by  CARM1 targeting other arginines, most likely 
H3R17 and H3R26. PRMT6 was not tested since this experiment was done as a 
preliminary step to transcription assays using CARM1 as a co-activator, but will 
be tested in future experiments.
52
Figure 3.3: Characterization of nucleosome assembly
Mononucleosome assembly quality was assessed by 5% native PAGE and EtBr 
staining. The faster migrating band is the uncomplexed 601 DNA fragment (left 
lane), while the assembled nucleosomes is the slower migrating band on the 
right.
3.3 Effects of H3R42 mutations on transcription 
With the knowledge that CARM1 can methylate H3R42 in the context of the 
nucleosome, I mutagenized the H3 sequence to generate arginine to lysine 
(R42K) or alanine (R42A) mutations. While both mutant residues cannot be 
modified by CARM1, R42K is a more conservative mutation since the potential 
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Figure 3.4: CARM1 methylates R42 in nucleosomes
(A) Left panel shows coomassie staining for the octamer (Oct.) and nucleosome 
(Nuc.) substrates after methltransferase reaction with CARM1; right panel 
shows the fluorogram of the indicated substrates. (B) Graph shows the relative 
abunbdance of R42me2a (in %) in the substrate as in (A). The exact amounts 
are also shown in the table below.
interaction with the DNA backbone is preserved due to the retention of the 
positive charge, while R42A also neutralizes the charge of the residue. Mutant 
histones were purified and assembled into octamers as described in the previous 
section.
Equal amounts of purified mutant and wild type octamers were used to 
reconstitute chromatin templates onto the plasmid DNA template illustrated in 
Figure 3.5A using a recombinant ACF/NAP1 system. The assay scheme used is 
the one in Figure 3.1A: p53 was used as activator and p300 as co-activator as in 
(An et al., 2004). The results of the transcription experiment are in Figure 3.5B: 
no transcription was observed in the absence of activator (lane 1). Minimal 
transcription was observed on the wild type template with p53 (lane 2), while 
mutations of R42 increased the transcription output, with R42A having a greater 
effect than R42K (lane 3 and 4). Lane 5 to 7 represent reactions with both p53 
and p300: as expected, p300 stimulated transcription from the wild type template 
(lane 5) and to a greater extent from the two mutant templates (lane 6 and 7).
These results show that mutation of H3R42 to lysine or alanine make 
chromatin templates more permissive to transcription. This might be due to the 
fact that arginine interacts with DNA better than lysine or alanine (Luscombe et 
al., 2001), creating a more permissive chromatin template. The bigger effect 
observed with the R42A mutation compared to R42K might account for the loss 
of positive charge. The increased transcription of the two mutants with p300 
compared to the wild type template could be explained by the fact that mutant 
nucleosomes might be easier to unwrap, therefore exposing some of the internal 
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Figure 3.5: Mutations of R42 affect in vitro transcription
(A) Schematic representation of the template used in transcription assays. It 
contains an adenovirus major late promoter, a tandem of five p53 binding sites 
and nucleosome positioning sequences. (B) p53-dependent, p300-mediated 
transcription activation in the presence of wild type or mutant H3R42A/K 
templates. Top  panel shows autoradiograph of the P32-labeled transcripts. The 
bottom graph shows the densitometric quantification of the transcripts. 
Transcription assay performed by Dr. Xiangdong Lu.
targets of p300 for easier acetylation. This speculation could be tested by 
incubating p300 with mutant or wild-type mononucleosomes, and quantifying by 
MS the different sites of acetylation.
Although this experiment demonstrates the importance of R42 in 
transcriptional activation, I felt that this system would not be optimal for analysing 
the direct effect of methylation of R42 by CARM1. To do so, we would have to 
compare the gain in transcription upon CARM1 addition between different 
templates, and since different templates have different basal activities, I felt that 
the comparison would not be fair. As a consequence, I decided to bypass the 
need for CARM1 methylation altogether and use designer histones pre-
methylated on R42. In addition to not requiring enzymatic reaction, designer 
histones are homogeneously modified, therefore maximizing the likelihood of 
observing an effect of the modification in transcription assays.
3.4 Generation of designer H3R42me2a histones
Generating H3R42me2a designer histones is technically  challenging because 
of the central location of the modification within the histone. The standard 
strategy for generating designer histones is based on a single ligation of one 
synthetic peptide harbouring the PTM of interest and one recombinant segment 
containing the remaining histone sequence (Shogren-Knaak and Peterson, 
2004). Asymmetric dimethyl arginine is only  available as an Fmoc-protected 
building block, and the Fmoc protection strategy is not reliable over long peptides 
(Larsen and Holm, 1994). Because of the central location of the modification, we 
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believed the best synthetic route to generate H3R42me2a designer histones 
would involve covalently ligating three polypeptide segments rather than two. A 
two-ligation strategy has been previously utilized to generate H3K56ac by  ligating 
3 peptides of synthetic origin (Shimko et al., 2011).
The semi-synthetic strategy utilized to generate designer histone H3 proteins 
harboring pre-modified R42me2a is illustrated in Figure 3.6. In this strategy, one 
segment is obtained using solid-phase peptide synthesis (SPPS) with a Boc 
protection strategy, one using SPPS with an Fmoc protection strategy, and one 
would be of recombinant origin. Particular attention was paid when selecting the 
appropriate ligation junctions, in order to obtain a “scar-less” product. Native 
chemical ligation requires an N-terminal cysteine for the reaction to occur: this 
leaves a residual cysteine at the ligation site. Unfortunately the only  cysteine in 
human H3.2 is present at position 110, therefore not useful for this ligation 
strategy. A  desulphurization reaction can be used to convert ligation-site 
cysteines to alanines (Wan and Danishefsky, 2007), such that alanines can be 
considered potential ligation sites. Given these considerations, we chose A29 
and A47 as ligation sites that allow generation of fully  native H3 with pre-modified 
R42. 
The recombinant segment (47- 135) was expressed in E. coli and purified 
from inclusion bodies. Alanine 47 was mutated to cysteine to allow subsequent 
ligation (A47C). Taking advantage of the generally benign mutation of the only 
cysteine in H3.2 to alanine (Luger et al., 1999a), a C110A mutation was 
engineered to prevent problems with the ligation steps.  No protein expression 
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Figure 3.6: Generation of semi-synthetic H3R42me2a protein. 
Schematic representation of the synthetic scheme utilized. See Materials and 
Methods for details.  and : solid phase peptide synthesis of H3(1-28) and 
H3(29-46;A29C,R42me2a);  ligation of the two synthetic peptides to generate 
H3(1-46;A29C,R42me2a);  final ligation step  of the recombinant fragment 
H3(47-135;A47C,C110A) to H3(1-46;A29C,R42me2a) followed by 
desulfurization to convert cysteines to alanines. Residue 42 is highlighted in 
yellow. Synthesis was carried out by Sam Pollock in the Muir Laboratory.
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Figure 3.6
was observed with the standard 6xHis tag used for purifying full-length histones. 
A longer construct with a 6xHis-SUMO tag resulted in successful expression. 
After purification, the tag was cleaved with overnight treatment with SUMO 
protease. Peptide 1 was synthesized corresponding to residues 1-28 of H3. 
Peptide 2 was synthesized corresponding to residues 29-46, bearing R42me2a, 
and an A29C mutation. Each segment was verified by MS analysis.
In the first step of the synthesis, peptide 1 was ligated to peptide 2, to give 
H3(1-46;A29C,R42me2a).  This intermediate product was purified and ligated to 
recombinant fragment H3(47-135,A47C) to give H3R42me2a(A29,47C;C110A), 
which was then purified by  HPLC chromatography. In the final step, a 
desulphurization reaction was used to convert the two cysteine residues to the 
native alanine residues present in H3. After HPLC purification, the production of 
the desired product was verified by mass spectrometry  (Figure 3.7). The final 
yield of purified designer histone was about 0.4 mg.
3.5 Preparation of designer octamers and chromatin templates
Semi-synthetic H3R42me2a was incorporated into core histone octamers with 
wild-type recombinant human H2A, H2B and H4 by salt dialysis as described in 
section 3.2. Removal of the 6xHis tags used for purification of H2A, H2B and H4 
was carried out by digesting with TEV and PreScission proteases overnight. 
Untagged designer octamers were purified by Superdex 200 size exclusion 
chromatography and confirmed by SDS-PAGE (Figure 3.8). Control unmodified 
histone octamers were formed containing recombinant human H3.2(C110A). 
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Unmodified and designer octamers were run side by  side on SDS-PAGE to 
confirm equivalent protein composition (Figure 3.9A).
Equal amounts of purified octamers were used to reconstitute chromatin 
templates onto the 5.4 kb plasmid DNA template described in Section 3.3 
(Figure 3.5A) using the ACF system as described previously. Characterization of 
assembled chromatin templates by incomplete micrococcal nuclease digestion 
and agarose gel electrophoresis revealed a 200 bp ladder of kinetic 
intermediates with both input octamers although the methylated input is lightly 
loaded compared to the unmodified one (Figure 3.9B), confirming that the quality 
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Figure 3.7: Confirmation of the production of H3(R42me2a)
Electrospray ionization mass spectrometry (ESI–MS) spectrum of purified 
H3(R42me2a). Charge states are labelled. (M+H)+ observed: 15,252 ±  4 Da; 
expected: 15,252 Da. MS characterization carried out by Sam Pollock.
of both unmodified and R42me2a chromatin is similar, and that R42 methylation 
does not prevent assembly of octamers into chromatin.
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Figure 3.8: Purification of designer octamers
H3(R42me2a) and recombinant H2A, H2B and H4 were assembled into 
octamers and purified by Superdex 200 size exclusion FPLC. The resulting 
chromatogram is shown, A280 absorbance graphed as a function of time. 
Octamer peak fractions were pooled as indicated (red box) and analyzed by 
SDS/PAGE and Coomassie staining 
3.6 Effect of H3R42me2a on in vitro transcription
Designer and unmodified chromatin templates were then used in the 
activator-dependent in vitro transcription system described in detail in Section 3.3 
and illustrated in Figure 3.5B. By  using the designer R42me2a template we 
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Figure 3.9: Chromatin template assembly with wild type and designer 
octamers
(A) Reconstituted octamer samples were analysed by SDS–polyacrylamide gel 
electrophoresis (SDS–PAGE) and staining with Coomassie blue. (B) 
Assembled chromatin was partially digested with MNase, and the recovered 
DNA was detected as described (An and Roeder, 2004). Chromatin assembly 
and MNase digestion was carried out by Dr. Xiangdong Lu.
tested whether H3R42me2a can act together with p300 activity  and stimulate 
transcription directly. As shown in Figure 3.10, in the presence of both p53 and 
p300 a 3-fold increase in transcription was observed from R42me2a over 
unmodified templates (compare lane 6 with lane 5). The reaction in absence of 
p300 was also performed: in these conditions R42 methylation resulted in a 
considerable (6-fold) increase in transcription versus unmodified template 
(compare lane 4 with lane 3). In the absence of activator p53 no transcription 
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Figure 3.10: H3R42me2a stimulates transcription in vitro. 
p53-dependent, p300-mediated transcription activation in the presence or 
absence of H3R42 asymmetric dimethylation. Top panel shows the 
autoradiograph of the P32-labeled transcripts. The bottom graph shows the 
densitometric quantification of the transcripts. Transcription assay performed by 
Dr. Xiangdong Lu.
was observed (lanes 1 and 2). In light of the results presented in the next 
Chapter, it is important to point out that the experiments shown here were carried 
out in the presence of the HDAC inhibitor sodium butyrate.
Taken together, these results demonstrate that methylation of H3R42 directly 
stimulates transcription in vitro, alone or in combination with the activity of co-
activator p300. To my knowledge this is the first time that a methylation in the 
nucleosome core is demonstrated to have such an effect. Natural extensions of 
these results will be to understand whether H3R42me2a also weakens the 
interaction with DNA and/or enhances the activity of nucleosome remodelling 
enzymes.
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Chapter 4. Effector-mediated consequences of H3R42 
methylation
Histone PTMs often result in promoting or blocking the recruitment of binding 
proteins to chromatin in what has been described as trans mechanisms (Allis et 
al., 2007). In Chapter 3, I described a direct effect of H3R42 methylation on 
transcriptional activation. The fact that this modification can directly  influence the 
properties of chromatin does not rule out the possibility  that this modification 
could have effector-mediated effects. In this Chapter, I describe experiments 
aimed at uncovering some of these effects.
4.1 Investigation of a  possible crosstalk with phosphorylation of 
H3Y41 by tyrosine-protein kinase JAK2
It has been proposed that pairs of neighboring modifiable residues in histones 
might not act independently but rather form cassettes (“binary switches”) where 
modification of each site depends on the other, and modification on one or the 
other residue will influence the recognition and binding of modules to the 
cassette (Fischle et al., 2003). For example, HP1 association with H3K9me3 is 
required for its localization to heterochromatin (Lachner et al., 2001). H3S10, 
adjacent to K9, is phosphorylated in M-phase by Aurora B kinase. HP1 binding to 
H3K9me3 is incompatible with H3S10phos, and this explains the observed 
dissociation of HP1 from chromatin during mitosis (despite no significant change 
in H3K9me3 levels) (Fischle et al., 2005; Hirota et al., 2005). This binary switch is 
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also played out at the enzyme level, with H3S10phos inhibiting H3K9 methylation 
by methyltransferase SUV39, and H3K9me3 inhibiting H3S10 phosphorylation by 
Aurora B (Rea et al., 2000) (Figure 4.1). 
Since H3R42 is adjacent to the phospho-acceptor tyrosine 41 (H3Y41) 
(Figure 4.1), I asked whether these two residues could constitute a cassette, as 
K9 and S10 do. Phosphorylation of H3Y41 by the kinase JAK2 prevents the 
binding of the chromo-shadow domain in Heterochromatin Protein 1α (HP1α) to 
this region of H3, therefore preventing silencing of JAK2 target genes (Dawson et 
al., 2009). 
I first tested whether H3R42 methylation affects the kinase activity of JAK2 by 
radioactive kinase assays on peptide substrates. Unmodified H3(34-52) peptides 
were effectively phosphorylated by recombinant JAK2, while mono- or 
dimethylation on R42 completely inhibited the activity (Figure 4.2A).
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Figure 4.1: Binary switches in histone H3
The partial sequence of human histone H3 is shown with highlighted the 
demonstrated K9/S10 binary switch and the putative Y41/R42 binary switch. 
Dotted lines with question marks indicate relationships that were tested 
experimentally in this thesis. Methylation is indicated with red M, phosphorylation 
with green P.
I then tested whether the binding of the chromo-shadow domain of HP1α was 
sensitive to H3R42 methylation. I purified the bacterially expressed 6xHis-tagged 
domain and used it in peptide pull-down experiments. Biotinylated H3(34-52) 
peptides (unmodified or methylated on R42) were conjugated to streptavidin 
beads and used as baits. The result in Figure 4.2B shows that the chromo-
shadow domain of HP1α binds to H3 peptides irrespective of methylation on 
R42.
Taken together, these results suggest a possible interplay  between Y41phos 
and R42me2, where R42 methylation might locally prevent JAK2 activity without 
affecting HP1α recruitment. Unfortunately, given the lack of reliable antibodies for 
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Figure 4.2: R42 methylation affects JAK2 activity but not HP1α binding
A) JAK2 activity was measured by quantifying the amounts of P32-phosphate 
deposited onto the peptide substrates indicated at the bottom of the graph . B) 
The recombinant chromoshadow domain (CSD) from HP1α was subjected to 
peptide pull-down with the biotinylated peptide indicated on top of the panels. 
After SDS-PAGE, proteins were stained by Coomassie.
R42me2a to be used in functional and genomic studies, I did not further 
investigate this putative crosstalk.
4.2 Identification of binders: candidate approach.
In contrast with the large number of proteins that specifically bind to 
methylated lysines, only two domains are known to recognize methylated 
arginines on histones. WDR5 has been shown to bind with its WD40 domain to 
symmetrically  dimethylated H3R2 (H3R2me2s), a mark deposited by  PRMT5 and 
PRMT7 (Migliori et al., 2012b). The Tudor domain protein TDRD3 has been 
identified as a specific binder of asymmetric dimethyl arginine on histones; in 
particular, TDRD3 binds H3R2me2a and H3R17me2a, two modifications 
catalyzed by the enzymes PRMT6 and CARM1, respectively  (Liu et al., 2012; 
Yang et al., 2010). 
Since my data demonstrates that R42 is dimethylated asymmetrically  by 
CARM1 and PRMT6, I tested whether TDRD3 could also bind H3R42me2a. For 
this purpose, I purified bacterially expressed GST-tagged Tudor domain from 
TDRD3 and used it in peptide pull-down experiments with biotinylated H3 
peptides. H3R17me2a peptides were used as positive control. I confirmed that 
the Tudor domain of TDRD3 binds very effectively  to peptides containing 
H3R17me2a. On the other hand, no binding was observed for modified or 
unmodified H3R42 peptides (Figure 4.3). This result indicates that TDRD3 is not 
a reader of H3R42me2a.
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4.3 Identification of binders: an unbiased approach.
Since the candidate approach described in the previous section did not prove 
successful, I opted for an unbiased approach and used peptide pull-down assays 
in my search for R42 binders. Our laboratory and others have successfully used 
this method to identify histone PTM readers (Wysocka, 2006; Wysocka et al., 
2005; Wysocka et al., 2006). Biotinylated histone peptides that are either 
unmodified or modified on the residue of interest are immobilized on avidin beads 
and incubated with nuclear extracts (Figure 4.4). After incubation and extensive 
washes, bound proteins are eluted from the beads and resolved by SDS–PAGE. 
Proteins differentially present in one of the two lanes are identified by mass 
spectrometry. Since unmodified and modified pull-downs are always carried out 
side by side, this method allows identification of effectors that either bind to 
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Figure 4.3: TDRD3 does not bind to H3R42me2a
The recombinant tudor domain from TDRD3 was subjected to peptide pull-down 
with the biotinylated peptide indicated on top of the panels. After SDS-PAGE, 
proteins were stained by Coomassie.
(factor X in Figure 4.4) or are blocked by (factor Z in Figure 4.4) methylation on 
H3R42. 
I first carried out the pull-down experiment following standard protocols 
(Wysocka, 2006) and incubating the resin-bound peptides with pre-cleared 
nuclear extracts from HeLa cells. As shown in Figure 4.5A, this method did not 
result in any differentially  represented band. I reasoned that the peptides used 
(residues 34-52 of H3) are positively charged and could therefore interact with 
nucleic acids present in the nuclear extract. The nucleic acids might in turn act as 
a bridge and bind to many DNA/RNA-interacting nuclear proteins and result in a 
high background, preventing the identification of putative R42 binders. To 
overcome this problem I treated the nuclear extracts with RNAse and ethidium 
bromide prior to incubation with the peptides, following a protocol introduced by 
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Figure 4.4: Schematics of the peptide pull-down assay. 
Biotinylated histone peptides either unmodified, or modified at R42 are 
immobilized on avidin beads and incubated with extract. Specific effector proteins 
bind to histone peptides in a modification-sensitive manner. Bound proteins are 
then eluted from the avidin beads, and resolved by  SDS–PAGE. Candidate 
readers are enriched in the modified (factor X), or unmodified (factor Z) peptide 
pull-down lane. Adapted from (Wysocka, 2006).
Peter Lewis, a post-doctoral associate from our laboratory. With this modified 
protocol, several bands appeared enriched in the pull-down lane of the 
unmodified peptide (Figure 4.5B). The experiments were repeated three times 
with independent extracts, and enriched bands (together with corresponding 
molecular weight bands from the modified pull-down) were sent for MS analysis 
at the Proteomics Resource Center of The Rockefeller University. Two 
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Figure 4.5: Unbiased peptide pull-down assays. 
Proteins recovered after peptide pull-down with R42me2a or unmodified histone 
peptides were resolved by SDS-PAGE and silver stained. (A) shows a 
representative experiment using untreated nuclear extracts, (B) shows a 
representative experiment with nuclear extract pretreated with RNAse and EtBr. 
The bands corresponding to NCOR1 and TBL1/R1 are highlighted.
polypeptides were consistently present in the unmodified peptide pull-down and 
not in the H3R42me2a one in all three replicates. These proteins were identified 
by MS as NCOR1 and TBL1/TBLR1 (highlighted in Figure 4.5B). All the proteins 
that were identified with high degree of confidence in these experiments are 
listed in Table 4.1.
NCOR1 and TBL1/R1 made interesting candidates for follow-up  experiments 
because they both belong to the N-CoR co-repressive complex. This complex 
represses the expression of target genes through the histone de-acetylase 
activity  of its subunit HDAC3, and is recruited to chromatin by several 
transcription factors, including nuclear hormone receptors (Perissi et al., 2010). 
Since the experiments presented in Chapter 3 suggested a role for H3R42me2a 
in transcriptional activation, it seemed plausible that methylation of R42 might 
prevent the binding of a repressive complex like N-CoR to chromatin. The 
experiments presented in the next sections are aimed at validating the binding 
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Table 4.1: List of factors identified by MS after peptide pull-down 
result and at understanding the mechanisms through which this interaction might 
affect gene expression.
4.4 Validation of H3:NCoR interaction
To validate the binding of the NCoR complex to unmodified R42 peptides, I 
repeated the peptide pull-down experiments from nuclear extracts as described 
previously. The resulting samples were run on SDS-PAGE and blotting was 
performed with antibodies specific to NCOR1. H2B, H3 and H4 N-terminal 
peptides were used as controls. The result shown in Figure 4.6A confirms that 
NCoR selectively  binds to unmodified H3(34-52), and not to R42me2a peptides 
or any of the control peptides.
To rule out the possibility that the binding observed might be an artifact due to 
the inherent complexity of the crude nuclear extract, and not be a direct 
interaction, I asked whether a purified N-CoR complex would show the same 
binding specificity. I obtained affinity-purified human NCoR complex from Dr. 
Tomoyoshi Nakadai, a post-doctoral associate from the Roeder laboratory at The 
Rockefeller University. Briefly, Flag-tagged NCOR1 was overexpressed in HeLa 
cells, purified using M2 anti-Flag affinity resin, and eluted with 3xFlag peptides. 
The purified complex was confirmed by MS analysis (Figure 4.6B). When used 
in peptide binding experiments, the purified complex recapitulated the binding 
pattern observed with nuclear extracts (Figure 4.6C). 
Taken together these results validate that the N-CoR complex interacts in 
vitro with H3 peptides containing R42, and that methylation on this residue 
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abolishes the binding. Interestingly, although a previous report had shown 
binding of N-CoR to H2B or H4 N-tail peptides (Yoon et al., 2003), I was not able 
to reproduce these results. This could be explained by differences in washing 
conditions used in pull-down experiments, or by differences in protein 
preparations.
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Figure 4.6: H3R42me2a prevents binding of the NCoR complex to H3. 
(A) Recovery of NCOR1 after peptide pull-down from HeLa nuclear extract, 
assayed by western blot. The peptides utilized are indicated at the top  of the 
panel. (B) Protein composition of the affinity-purified NCoR complex. Proteins 
were resolved by SDS-PAGE and silver stained. (C) Recovery of affinity-purified 
NCoR complex after pull-down with the peptides indicated at the top of the panel. 
Western blot (WB) probed with anti-Flag (NCOR1) and anti-TBL1 antibodies. 
4.5 Molecular basis of H3:NCoR interaction
With data suggesting a direct interaction between N-CoR and H3, I sought to 
investigate which protein domain(s) within the complex could mediate this 
interaction. I used the SMART protein domain prediction algorithm (http://
smart.embl-heidelberg.de/) and interrogated the sequences of each known 
subunit of the complex for the presence of known histone binding domains.
The subunits TBL1 and TBLR1, two highly similar components of N-CoR, 
both contain 7-blade WD40-repeat domains (Figure 4.7A). I chose these 
domains as candidate binders since several WD40-repeat domains have been 
shown to specifically recognize the methylation states of histone arginines 
(Migliori et al., 2012a).
To test the binding of the WD40 domains, I expressed both in E. coli and 
purified them as GST-tagged recombinant proteins. When used in peptide pull-
down experiments (Figure 4.7B), both domains behaved similarly: they 
displayed binding to unmodified R42 peptides, but not to methylated R42 
peptides or control peptides. To rule out the possibility that the binding observed 
might be a result of stickiness due to improper folding of the bacterially-produced 
proteins, I synthesized the same protein domains in vitro using reticulocyte 
lysates, and labeled them with 35S-methionine. Peptide pull-down followed by 
SDS-PAGE and autoradiography (Figure 4.7C) confirmed binding of both 
domains to unmodified R42 peptides.
The data presented in this section demonstrates a direct interaction of the 
WD40 domains in TBL1 and TBLR1 with an internal H3 peptide centered on R42. 
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The binding appears to be sensitive to R42 methylation, providing an effector-
mediated role for this new modification. In addition to the C-terminal WD40 
domain, TBL1/R1 contain an N-terminal tetramerization domain. The tetrameric 
nature of TBL1/R1 suggests that the proteins may serve as a scaffold for a 
multivalent chromatin-targeted repressive complex that also contains HDAC 
activity. Indeed, comparison of the predicted size of the complex with a di-
nucleosome also suggests that the complex may be able to simultaneously target 
HDAC3 activity to multiple nucleosomes (Watson et al., 2012) (Figure 4.8).
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Figure 4.7: WD40 domain in TBL1 bind to H3(34-52)
(A) Domain structure of TBL1 and TBLR1. (B) Peptide pull-down of recombinant 
WD40-repeat domains from TBL1 and TBLR1. The proteins were resolved by 
SDS-PAGE and visualized by anti-GST western blot. (C) Peptide pull-down of in 
vitro-translated WD40-repeat domains from TBL1 and TBLR1. The radiolabeled 
protein is visualized by autoradiography after SDS-PAGE.
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Figure 4.8: Model of NCoR complex binding to nucleosomes
Synthesis of the structural data to yield a global illustrative model of the core 
NCoR complex including WD40 domains for TBL1 (green & cyan disks), HDAC 
(grey) and NCOR (purple). A  di-nucleosome is shown to the right to illustrate the 
relative scale of the chromatin substrate, suggesting binding to two adjacent 
nucleosomes. Adapted from (Watson et al., 2012).
4.6 Effects of binding on complex recruitment and activity
As described in Chapter 1, histone PTMs that act in trans can influence either 
the recruitment of effector proteins to chromatin or the enzymatic activity of 
effector proteins on chromatin. 
I first asked whether the observed negative effect of R42me2a on N-CoR 
binding to H3 peptides affected the overall chromatin recruitment of the complex. 
To this end, I compared the nuclear salt extraction properties of N-CoR in cells 
with different levels of H3R42me2a. Since CARM1 appeared to play a dominant 
role in controlling the levels of this modification (as discussed in Chapter 2) I 
chose to compare CARM1 +/+ and -/- MEFs. The double-negative cells showed 
in fact over 50% reduction in R42 methylation by MS (Figure 2.10B). Briefly, I 
isolated nuclei by hypotonic lysis from CARM1 +/+ and -/- MEFs, and incubated 
them with buffer containing increasing amounts of NaCl to sequentially  extract 
proteins from chromatin. Western blot for NCOR1 was carried out to follow the 
extraction profile of the complex (Figure 4.9). Immunoblots for WDR5 and H3 
were used as controls. The extraction profile for NCOR1 does not differ in either 
cell line, suggesting that H3R42 methylation may not influence the recruitment of 
N-CoR to chromatin. This is consistent with the report of N-CoR being recruited 
to chromatin via interaction with several DNA-binding transcription factors 
(Perissi et al., 2010).
In light of this I asked whether binding of N-CoR to H3 could allosterically 
affect the enzymatic activity of HDAC3 within the complex. This would be similar 
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to the situation reported for the PRC2 histone methyltransferase complex, where 
the WD40-repeat subunit Eed binds to H3K27me3 peptides and increases the 
methyltransferase activity of the complex (Margueron et al., 2009). To test this 
hypothesis, I measured HDAC activity with commercially-available fluorescent 
HDAC activity assays (Active Motif catalog # 56200), using affinity-purified N-
CoR complex and addition in trans of increasing amounts of unmodified or 
R42me2a H3(34-52) peptides, or of H4(1-20) peptide as a control. The 
fluorescent assay kit utilizes a proprietary short peptide substrate that contains 
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Figure 4.9: Salt extraction properties of N-CoR.
Western blot (WB) for NCOR1, WDR5 and H3 after sequential salt extraction 
from nuclei purified either from CARM1 +/+ or CARM1-/- MEFs. 
an acetylated lysine optimized for HDAC3 (as well as other HDACs). Once the 
substrate is deacetylated, the lysine residue reacts with a developing solution 
releasing a fluorescent product, which can be quantified using a fluorescent plate 
reader. As shown in Figure 4.10A, addition of unmodified H3(34-52), but not the 
other two tested peptides, caused a concentration-dependent increase in the 
HDAC activity of the complex. 
I then asked whether this stimulatory effect translated into different levels of 
acetylation in vivo. To do this, I compared by western blot the levels of histone 
lysine acetylation in CARM1 +/+ and -/- MEFs. In agreement with the observed 
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Figure 4.10: H3R42me2a prevents stimulation of N-CoR
(A) HDAC activity of purified NCoR complex with increasing amounts of H3 
peptides added in trans, measured by fluorescence. (B) Levels of acetylated 
histones, CARM1 and H3 in extracts from CARM1 +/+ or CARM1-/- MEFs 
measured by anti-Kac western blot. Middle panel confirms absence of CARM1 
in CARM1-/- MEFs. Western blot for H3 in the bottom panel is a control for 
loading.
stimulation of HDAC activity upon H3 binding, I observed that the amounts of 
acetylated lysines on histone H3 and H4 are larger in CARM1 +/+ than in 
CARM1 -/- MEFs (Figure 4.10B). 
Taken together, these results suggest a role for H3R42me2a in protecting 
chromatin from deacetylation, by negating a stimulatory effect on the HDAC 
complex N-CoR. Although preliminary, this observation is potentially very 
interesting and provides a novel mechanism through which histone acetylation 
levels can be regulated.
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Chapter 5. Discussion
Methylation of arginines on histone tails has been linked to both 
transcriptional activation and repression (Bedford and Clarke, 2009). The 
experiments presented in this thesis show for the first time that a methylated 
arginine at the interface between DNA and histones, H3R42, targeted by 
methyltransferases CARM1 and PRMT6, has a dual transcriptional activating 
role: H3R42me2a both prevents histone deacetylation and affects the biophysical 
properties of chromatin, making it easier to be transcribed in in vitro transcription 
assays.  While uncertainties remain as to the actual mechanisms that bring about 
these dual effects, these findings call attention to H3R42 methylation as 
influencing both enzyme activities and substrate properties in the promotion of 
transcriptional activation.
5.1 Methylation of residue 42 of histone H3 is conserved through 
evolution
In Chapter 2 I used an antibody-enrichment strategy combined with mass 
spectrometry to identify novel arginine methylation sites in human histones. The 
rationale for using an enrichment step was based on the notion that arginine 
methylation is a rare PTM in histones. This approach led me to the identification 
of dimethylated arginine 42 of histone H3 (H3R42) in both human and mouse 
cells, a residue at the DNA entry/exit region of the nucleosome (Figure 2.2 and 
2.10). 
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Histones are among the most conserved proteins in eukaryotes (Malik and 
Henikoff, 2003). Residue 42 in histone H3 shows an amino-acid change with 
functional conservation: S. cerevisiae “evolved” a lysine at this position while 
most other organisms have arginine (Figure 1.8B). Both arginine and lysine are 
basic residues and have the potential to create electrostatic interactions or 
hydrogen bonds with DNA, suggesting that this contact is structurally important. 
Upon discovery of the H3R42me2 mark, I hypothesized that, given the particular 
location within the nucleosome structure, this modification could play a role in 
transcriptional activation. My hypothesis was further supported by work from 
Boeke and colleagues (Hyland et al., 2011): they, in fact, discovered that H3K42 
is dimethylated in budding yeast as well, and that mutation to alanine (K42A) 
results in a widespread increase in transcription. These findings, together with 
mine, suggest that methylation of residue 42 in histone H3, whether that residue 
is a lysine or an arginine, is a conserved and important regulatory modification 
that may modulate the tightness of interaction between DNA and the histone 
octamer. 
Since organisms as phylogenetically distant as yeast and humans maintained 
methylation of residue 42 in H3 as a mechanism to modulate transcription, it will 
be interesting to see if this PTM can also be found in other organisms. 
5.2 Both CARM1 and PRMT6 methylate R42 in vivo.
In Chapter 2 of this thesis I demonstrated that CARM1 and PRMT6 can 
methylate H3R42 in vitro on peptide substrates (Figures 2.5 and 2.8), and that 
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both enzymes regulate the level of H3R42me2a in vivo (Figures 2.9 and 2.10). 
The two identified methyltransferases fit with the initial hypothesis that 
H3R42me2a is a mark involved in transcriptional activation. CARM1 was 
originally identified as a transcriptional co-activator for nuclear steroid receptors 
(Chen et al., 1999) and its positive role in transcriptional activation is well 
established (An et al., 2004). On the other hand, PRMT6 activity has generally 
been associated with transcriptional repression (Guccione et al., 2007; Hyllus et 
al., 2007; Iberg et al., 2007), although more recently  it has been reported that 
PRMT6 can positively regulate a group of nuclear receptor target genes 
(Harrison et al., 2010). 
My data demonstrates that both enzymes are important in controlling the 
overall level of R42 methylation in vivo. Given this overlap, an outstanding 
question remains: do both enzymes target the same or different genomic 
locations? Or is there a cell-specificity for the use of either enzyme? Or a time-
specificity in the cell cycle? Interestingly, the activity of CARM1 on H3R17 has 
been shown to increase in M phase (Sakabe and Hart, 2010), it is therefore 
possible that methylation of H3R42 might follow a similar behaviour. The lack of a 
specific antibody for H3R42me2a prevented me from answering these questions. 
Should this reagent become available, it would be very  interesting to map 
H3R42me2a in the genome and study how the localization of this PTM is 
affected by CARM1/PRMT6 knockdown/overexpression. It is possible that 
redundancy exists between the two enzymes and that the activity of one might 
influence the activity of the other.
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At the enzyme level, it also remains unclear whether CARM1 and PRMT6 
deposit methyl groups on their tail sites and R42 at the same time. This could be 
addressed with in vitro methylation experiments on recombinant nucleosomes 
followed by MS analysis to quantify  all the modifications. Unfortunately both 
H3R17 and H3R2 (the major sites previously mapped for CARM1 and PRMT6, 
respectively) are within tryptic peptides that are not suitable for the current 
quantification methods used in the Garcia laboratory (personal communication).
It is possible that interaction with different factors might impart different 
specificities to the enzymes or cause their recruitment to different regions. I show 
in Figure 3.4B that recombinant CARM1 methylates H3R42 less efficiently  when 
in a nucleosome context compared to octamer. This can be explained by  the fact 
that the DNA might partially block the enzyme from targeting this site. It is very 
likely  that efficient R42 methylation in vivo requires the activity of nucleosome-
remodelling enzymes. In support of this hypothesis, it has been shown that 
CARM1 co-purifies with several components of the ATP-dependent SWI-SNF 
chromatin remodelling complex, and that this interaction enhances its 
methyltransferase activity  (Xu et al., 2004). Future experiments aimed at 
purifying specific interactors for both enzymes will help gain a better 
understanding of this aspect.
5.3 H3R42me2a as a direct modulator of transcription
In Chapter 3, I asked whether methylation of H3R42 had an effect on in vitro 
transcription. With the use of a designer histone strategy combined with in vitro 
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transcription assays, I showed that H3R42me2a makes chromatin templates 
intrinsically  better substrates for transcription (Figure 3.10). This result was 
obtained through productive collaborations with the Muir and Roeder 
laboratories. 
I speculate that the observed increase in transcription is due to the weakening 
of the interaction between H3R42 and DNA when the residue is methylated. I am 
currently  testing this hypothesis by assembling unmodified or designer 
(H3R42me2a) mononucleosomes and incubating aliquots at increasing salt 
concentrations. After PAGE and ethidium bromide staining I should be able to 
quantify the degree of DNA unwrapping from the nucleosomes (free DNA 
migrates faster than DNA complexed with histones), and compare it between the 
two kinds of input nucleosomes. Although a rigorous proof is still lacking, several 
previously reported observations support this hypothesis: 1) the DNA entry/exit 
region is important in controlling the unwrapping of DNA from nucleosomes 
(North et al., 2012); 2) mutation of residue 42 to alanine makes nucleosomes 
more mobile (Somers and Owen-Hughes, 2009); 3) mutation of residue 42 to 
alanine in S. cerevisiae results in a hyper-transcription phenotype (Hyland et al., 
2011).
This speculation is also in agreement with the finding that H3R42A mutant 
chromatin is a better substrate for transcription than H3R42K, and that both 
mutants are better substrates than wild type (Figure 3.5). Mutation to alanine, in 
fact, abolishes the positive charge at this position and eliminates interaction 
potential with DNA; lysine, while still retaining the charge, is a worse DNA-
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interactor than arginine (Luscombe et al., 2001). This is particularly interesting 
from an evolutionary standpoint: S. cerevisiae is one of the few organisms that 
has a lysine at position 42 and this might be explained by the fact that only 
~1.5% of human DNA is coding, relative to 50% for S. cerevisiae, and that the 
baseline state of yeast chromatin is less compact and repressive (Alberts, 2008; 
Lohr and Hereford, 1979). By having a lysine instead of an arginine at position 
42, S. cerevisiae makes its chromatin potentially  more permissive to 
transcription.
 
5.4 H3R42me2a as “protection” from deacetylation
Although the findings discussed in the previous sections argue for a cis effect 
of H3R42me2a, I did not want to rule out the possibility  a priori that this 
modification might have effector-mediated consequences. Binding of effector 
proteins in this region of H3 is, in fact, possible: binding of the chromoshadow 
domain of HP1α extends between residues 37 and 56 of H3 (Richart et al., 
2012), a region that also includes R42. This may  look surprising given that this 
region should be sterically occluded by the presence of DNA (Figure 1.8A). It 
has been shown that the DNA at the entry/exit point can unwrap  spontaneously 
from the nucleosome, and that, in physiological conditions, nucleosomes are in 
equilibrium between wrapped and partially  unwrapped states (Li and Widom, 
2004). This also explains how recombinant CARM1 can methylate R42 in a 
nucleosome context (Figure 3.4).
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In Chapter 4, through unbiased peptide pull-down experiments, I demonstrate 
that the N-CoR complex binds to histone H3 in a region centered on R42, and 
that the dimethylation of H3R42 prevents this binding (Figure 4.5 and 4.6). The 
binding observed is direct through the WD40 repeat domains in the subunits 
TBL1/TBLR1 (Figure 4.7). This finding is very interesting since no function has 
been assigned yet to those domains, although it has been hypothesized that they 
might mediate interactions with nucleosomes (Oberoi et al., 2011). No 
tridimensional structure of the TBL-WD40 domains is available, so it is hard to 
predict which residues could be involved in the observed binding. I will attempt to 
design mutants based on conservation or structure prediction algorithms to find 
ones that negate the binding. 
Using in vitro deacetylase assays, I also showed that binding of the N-CoR 
complex to H3 stimulates the intrinsic histone deacetylase activity  of the complex 
(Figure 4.10), although the mechanism underlying this stimulatory effect remains 
unclear. It is possible that the catalytic subunit HDAC3 itself “senses” the lack of 
methylation on R42 and that this stimulates its enzymatic activity. I am planning 
to test this hypothesis by using recombinant HDAC3, instead of the purified 
NCoR complex, in the same in vitro deacetylase assays. Another more likely 
possibility is that binding of TBL1/R1 to H3 induces a conformational change in 
the complex that renders it more active. This could be tested by using histone 
binding-deficient TBL mutants in the same HDAC assays.
The overall observation of H3R42me2a protecting from histone deacetylation, 
fits well with the demonstration that H3R42me2a stimulates transcription in vitro. 
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Figure 5.1: Model for H3R42me2a function
H3R42me2a stimulates transcription by making chromatin intrinsically more 
open and by protecting histones from deacetylation
Interestingly, a recent report suggests that the two previously known sites of 
methylation on the H3 N-tail catalyzed by CARM1 (H3R17me2a and R26me2a), 
also prevent histone deacetylation by  blocking the binding to chromatin of co-
repressor complexes NuRD and TIF1 (Wu et al., 2012). Taken together, these 
observations suggest a general role for CARM1 activity as a protective 
mechanism against deacetylation. 
5.5 Summary and perspective
While several groups have shown the direct effects of acetylation of specific 
lysines on the lateral surface of the nucleosomes (Manohar et al., 2009; 
Neumann et al., 2009; Shimko et al., 2011; Simon et al., 2011; Tropberger et al., 
2013), the experiments presented in this thesis are the first, to my knowledge, to 
examine the effects of methylation events within the nucleosome lateral surface. I 
identified H3R42 as a novel methylation site in mammalian cells in keeping with a 
conserved function in evolution and with a role in stimulating transcription. With a 
combination of mass spectrometry  and in vitro enzymatic reactions, I 
demonstrated that R42 can be dimethylated and that CARM1 and PRMT6 are 
the relevant methyltransferases. I show a dual-effect role for this mark: 1) to 
facilitate a structural alteration in the chromatin, making it easier to transcribe in 
our transcription assays; and 2) to “protect” the chromatin template from N-CoR-
mediated histone deacetylation. 
The model that arises from these findings is shown in Figure 5.1. In the initial 
state, a hypothetical target gene is maintained repressed by the HDAC activity of 
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N-CoR (and potentially other deacetylase complexes). Local CARM1/PRMT6 
activity  results in decompaction of chromatin due to H3R42 methylation. Because 
of the inefficiency of R42 methylation by recombinant CARM1 on nucleosomes 
compared to free octamers (Figure 3.4B), it is possible that nucleosome 
remodeling activities might be necessary to help expose the target residue. 
H3R42me2a in turn prevents histone deacetylation by N-CoR, and as a result 
histone acetylation increases, further increasing chromatin decompaction and 
transcriptional activation. I propose that H3R42me2a might be deposited at 
specific genomic locations to modulate the expression of target genes and to 
prevent their silencing brought about by histone deacetylation. 
Several other arginines on the DNA path in the nucleosome have been found 
to be methylated in large-scale proteomic studies (Cosgrove et al., 2004; Tan et 
al., 2011). In Figure 1.7 I highlighted where these arginines are located on the 
X .laevis nucleosome structure. H3R52 and H3R53 are at the DNA entry/exit 
point and it can be hypothesized that methylation on these residues might have 
very  similar effects to methylation of H3R42. Interestingly, R52A or R52K mutants 
are lethal in S. cerevisiae, suggesting a critical role for this residue in chromatin 
structure (Hyland et al., 2005). H3R63, H4R35, H2AR42, H2AR77 and H2BR83 
are also on the lateral surface of the nucleosome, but outside of the DNA entry/
exit point: H3R63 and H4R35 make hydrogen bonds with phosphate groups in 
the DNA major grove, while H2AR42, H2AR77 and H2BR83 penetrate the minor 
grove to form hydrogen bonds with DNA bases (Luger et al., 1997).  Given the 
buried nature of these residues, it is very unlikely that reader proteins can 
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interpret their modified state. Also, methylation must occur either in the absence 
of DNA (pre-deposition) or mechanisms must exist to temporarily  expose the 
nucleosome lateral surface to modifying enzymes. I predict that methylation on 
these residues affects directly the stability and intrinsic properties of 
nucleosomes and chromatin, resulting in effects to DNA-templated processes 
that include, but are not limited to, transcription.
With the work presented in this thesis I demonstrated that methylation can 
directly alter the properties of chromatin, and I envision that by extending these 
studies to other strategically placed methylations, we will be able to understand 
how histone:DNA interactions are dynamically modulated and lead to changes in 
downstream chromatin structure and function.
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Materials and Methods
Antibodies and Plasmids  
Anti-CARM1, anti-PRMT6, anti-NCOR1, anti-TBL1 and anti-WDR5 antibodies 
were purchased from Bethyl Laboratory. Anti-H3 antibody was obtained from 
Millipore (Billerica, MA). Anti-pan(Kac) was purchased from PTM Biolabs. Anti-
H3(R17me2a) and anti-mono and dimethyl arginine (ab412) were purchased 
from Abcam.
The plasmids encoding the Flag-HA-tagged PRMTs were kindly provided by 
Dr. Ernesto Guccione (IMCB, Singapore). For bacterial expression, the ORFs for 
CARM1 and PRMT6 were cloned into plasmid pGEX-6p1 (GE Life Sciences, 
Piscataway, NY). The TBL1 and TBLR1 constructs were as described in (Yoon et 
al., 2003) and were obtained from Dr. Jiemin Wong.
Dharmacon ON-TARGETplus SmartPool siRNAs against CARM1 and 
PRMT6 were purchased from Thermo Scientific.
Cell Lines and Regents 
HEK293 cells and HeLa cells were from ATCC. CARM1-/- and +/+ MEFs were 
obtained from Mark Bedford’s Laboratory. Cells were maintained in DMEM 
(Invitrogen, Grand Island, NY) supplemented with 10% FBS (PAA, Westborough, 
MA). TransIT®-LT1 Transfection Reagent (Mirus Bio, Madison, WI) was used for 
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plasmid transfections. DharmaFECT Transfection Reagents  (Thermo Scientific) 
were used for siRNA transfections. 
Nuclear Extract Preparation
Nuclear extracts were prepared according to the Dignam and Roeder method 
(Dignam et al., 1983). Briefly, cells were swelled in hypotonic buffer (10mM 
Hepes pH 7.9, 10mM KCl, and 1.5mM MgCl2) and then lysed by mechanical 
disruption in low salt buffer (20mM Hepes pH 7.9, 25% glycerol, 1.5mM MgCl2, 
20mM KCl). Soluble nuclear were then extracted by dropwise addition of high 
salt buffer (20mM Hepes pH 7.9, 25% glycerol, 1.5mM MgCl2, 1.2M KCl) to a 
final KCl concentration of ~320mM KCl, leaving behind the chromatin pellet.  
Acid Extraction of Histones and Enrichment 
Histones were purified by acid extraction as previously  described (Shechter et 
al., 2007). Briefly, nuclei were purified by resuspending cells in hypotonic lysis 
buffer (10 mM Tris–Cl pH 8.0, 1 mM KCl, 1.5 mM MgCl2 and 1 mM DTT). Nuclei 
were resuspended in nuclei in 0.4 N H2SO4 and the soluble proteins were 
precipitated by adding 33% TCA (Sigma). 
For the initial enrichment strategy, we first obtained a chromatin pellet from 
HeLa cells following the classic Dignam and Roeder nuclear extract preparation. 
The final pellet was then acid extracted and the resulting extract was 
resuspended in PBS supplemented with 0.1% NP-40 and incubated for 4 hours 
with anti methyl-arginine antibodies (ab412). After incubation with Protein A/G 
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agarose beads, the bound proteins were eluted in 100 mM Glycine pH 2.5 and 
analyzed by MS. 
Liquid Chromatography Mass Spectrometry and Sample 
Preparation
MS analysis was performed by Gary LeRoy in Benjamin Garcia’s laboratory, 
then at Princeton University. Histones were propionyl derivatized with propionic 
anhydride, trypsinized and prepared for MS as described in (Plazas-Mayorca et 
al., 2009) with minor adjustments. 2-Propanol was substituted for Methanol 
during the derivatization reaction. Histone peptides were separated by reverse 
phase nanospray liquid chromatography on C18 resin with an Agilent 1200 series 
HPLC. Mass spectrometry was performed on a LTQ-Orbitrap mass spectrometer 
(ThermoFisher Scientific).
Mass Spectrometry Data Analysis
All MS/MS spectra were processed with the Bioworks 2.0 program using the 
Sequest algorithm. The MS/MS database searching parameters included a 
precursor tolerance of 0.1 Da, and fragment tolerance of 0.5 Da. Computer 
searches were performed using the trypsin protease enzyme parameters (with up 
to 3 missed cleavages) against a database with the human Histone sequences. 
A static modification of 56 Da for N-terminal propionylation and dynamic lysine 
and arginine modifications of 14 Da (methylation), 28 Da (dimethylation or 
formylation), 42 Da (trimethylation or acetylation), 56 Da (propionylation), and 
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serine/threonine phosphorylation (80 Da) were used in the computer searches. 
Lastly, all data from modified peptides were manually inspected with the 
Bioworks 2.0 program.
Quantification of H3R42me2
Quantification of the propionylated/triptic histone H3 peptides (a.a. 41-49) Pr-
YRPGTVALR (+/- R42me2) was accomplished by measuring the area under the 
XIC peaks corresponding to the +2 charged precursor ions to Pr-YRPGTVALR 
(544.815 m/z) and Pr-YRme2PGTVALR (558.831 m/z).  Relative quantification 
was accomplished by comparing such XIC peak data from the Pr-
YRme2PGTVALR ion to the Pr-YRPGTVALR ion.   
Enzymatic Assays on Peptides
Cells were transfected with plasmids expressing Flag-HA-tagged human 
PRMTs. 48 hours after transfection, cells were washed with ice-cold PBS and 
lysed with 1 ml of IP buffer (50 mM Hepes (pH 7.8), 250 mM NaCl, 0.5% Nonidet 
P-40) with protease inhibitor cocktail. Insoluble materials were removed by 
centrifugation. Whole cell lysates were incubated for 2 hours at 4°C  with 5 ul of 
EZview Red Anti-HA beads (Sigma). After extensive washes, the beads were 
incubated with 1 ug of histone H3 peptides for 2 h at 30°C  in HMT buffer (PBS, 1 
mM DTT) with 2 ul 3H-Adomet (1 uCi, Perkin-Elmer). Tritiated labeled proteins 
were run on SDS-PAGE, stained with Coomassie R-250 dye, soaked in Amplify 
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solution (GE Healthcare) for 30 min, vacuum-dried onto filter paper, and exposed 
to x-ray film; exposures ranged from overnight to 1 week at -80 °C.
Recombinant GST-CARM1 and GST-PRMT6 were purified from E. coli using 
standard methods. Cells were disrupted by high pressure on an Emulsiflex 
(Avestin) in PBS supplemented with 500 mM NaCl, 1 mM DTT and protease 
inhibitor cocktail tablets (Sigma), and the cleared lysates were incubated with 
Glutathione-Sepharose 4B resin (GE Healthcare). After extensive washes bound 
proteins were eluted with 20 mM reduced glutathione. 1 ug of each enzyme was 
incubated with 1 ug of histone H3 peptides for 1 h at 30°C  in HMT buffer with 2 ul 
3H-Adomet. The reaction mix was spotted on P81 filter paper and air-dried. After 
washing five times with 100 ml of sodium carbonate buffer (0.1 M, pH 8.5) and a 
final wash with acetone, the filter papers were air-dried and put into scintillation 
vials containing 2.5 ml of scintillation liquid. Counts per minute (cpm) were 
measured via a scintillation counter (Beckman).
Recombinant JAK2 was purchased from Active Motif. As per manufacturer’s 
instructions, 0.1 ug of active kinase was incubated with 1 ug peptide substrate in 
reaction buffer (60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 µM 
Na-orthovanadate, 1.2 mM DTT, 2.5 µg/50 µl PEG20.000) and 1 uCi of 
gamma-32P ATP (Perkin-Elmer) for 30 minutes at 37°C. The reaction mix was 
spotted on P81 filter paper and air-dried. After washing five times with 100 ml of 
1% phosphoric acid and a final wash with acetone, the filter papers were air-dried 
and put into scintillation vials containing 2.5 ml of scintillation liquid. Counts per 
minute (cpm) were measured via a scintillation counter (Beckman).
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The peptides used in these assays (H3(1-20), H3(34-52), H3(34-52)R42me1 
and H3(34-52)R42me2a) were synthesized by  the Rockefeller University 
Proteomics Resource Center (New York, NY).
In vitro citrullination assay 
Purified PAD4 (a gift from Dr. Sonja Staedler) was incubated with substrates 
in Assay Buffer (100 mM Tris-HCl, pH 7.4, containing 5 mM DTT and 2 mM 
CaCl2) for 30 min at room temperature. The reactions were stopped by the 
addition of 5 × SDS-PAGE sample loading buffer and analyzed by Western blot 
after SDS-PAGE. Citrulline was detected using an anti-citrulline (modified) 
detection kit (Upstate, Millipore).
Peptide synthesis 
Peptides were synthesized by Sam Pollock in Tom Muir’s laboratory  at 
Princeton University. 
Amino-acid derivatives, chlorotrityl resin and coupling reagents were 
purchased from Novabiochem. 
Peptide 1: The sequence corresponding to residues 1-28 of human H3.2 was 
synthesized on a mercaptopriopionamide-Arg-PAM resin, which affords a peptide 
α-thioester upon cleavage. Chain assembly employed manual solid-phase 
peptide synthesis with a t-butyloxycarbonyl (Boc) Nα  protection strategy  and 
using 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
(HBTU) for amino-acid activation. The peptide was cleaved from the resin on a 
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500mg peptide-resin scale by stirring in 10mL anhydrous HF (Sigma) at 0° C for 
1hr with p-Cresol (Sigma) as a scavenger before work-up  in cold ether, 
dissolution in 50% solvent B, and lyophilization. Cleaved product was purified by 
RP-HPLC, yielding approximately 35mg peptide 1 which was characterized by 
electrospray mass spectrometry; measured mass = 3239.8 Da, predicted = 
3239.8 Da.
Peptide 2: The sequence corresponding to residues 29-46 of  human  H3 
containing a Ala29-Cys mutation and  was synthesized on 2-chlorotritylhydrazine 
resin (~0.4mmol/g), which was derived as described previously (42). The peptide 
itself was synthesized using manual solid-phase peptide synthesis with a 
fluorenylmethyloxycarbonyl (Fmoc) Nα  protection strategy and using HBTU for 
amino-acid activation (Sigma). The peptide was cleaved from the resin on a 
500mg peptide-resin scale by shaking in 10mL 95:2.5:2.5 TFA:H2O:TIPS 
(triisopropylsilane) at room temperature for 1.5hr before rotary evaporation of the 
TFA and work-up  in cold ether, dissolution in 50% solvent B, and lyophilization. 
Cleaved product was purified by RP-HPLC, yielding approximately 30mg peptide 
2 which was characterized by electrospray mass spectrometry; measured mass 
= 1966.1, predicted = 1966.1 Da.
Preparation of H3(47-135)A47C,C110A
A template pET3 plasmid containing hH3.2 was amplified by PCR to afford a 
fragment containing residues 47-135 with a Ala47-to Cys mutation. This was 
inserted into a  pET30a(-) vector plasmid containing N-terminal poly-His and 
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SUMO elements and verified by  DNA sequencing. E. coli  BL21(DE3) cells 
(Invitrogen) transformed with the above His-SUMO-H3(47-135, A47C) construct 
were grown in Luria-Bertani (LB) medium at 37  °C until mid-log phase, and 
protein expression was induced by the addition of 0.6 mM IPTG and allowed to 
continue at 37°C for 4 hr. After harvesting the cells by  centrifugation at 3,000g for 
20 min, the cell pellet was resuspended in lysis buffer (50 mM Tris, 200 mM NaCl, 
1 mM EDTA, pH 7.5) and frozen at -80 °C. Thawed cells were lysed by sonication 
and passage through a French press and the soluble material was removed by 
centrifugation at 30,000g for 30 min. The inclusion bodies, containing the desired 
fusion protein, were re-dissolved in lysis buffer + 6M guanidinium chloride 
(GuHCl) for 3hr and the solution was centrifugated as before and the supernatant 
incubated for 1.5hr at 4  °C with Ni-NTA resin (Qiagen) pre-equilibrated in lysis 
buffer + GuHCl. The resin was washed with 10 column volumes (CV) of D500 
(6M GuHCl, 50mM Tris, 500mM NaCl, 3mM β-mercaptoethanol, pH 8.0) and 
10CV D1000 (D500 with 1M NaCl) followed by 5CV urea buffer (6M urea, 50mM 
Tris, 150mM NaCl, pH 7.9). Elution was carried out with 7x1mL elution buffer 
(urea buffer +  500mM imidazole).  Fractions were analyzed by SDS-PAGE and 
combined before immediately undertaking cleavage of the His-SUMO tag. 
Proteolytic cleavage of the His-SUMO-H3 construct proceeded under the 
following conditions: the construct was diluted in cleavage buffer to afford a final 
concentration of 2M urea, 166mM imidazole, (2mM DTT, 150mM L-Arginine, 
10mM L-Cysteine, 50mM Tris, 150mM NaCl, pH 8) and 1U Ulp1 SUMO protease 
per 100ug cleavable material . The final concentration of fusion protein was 
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~0.25 mg/mL. The solution was left overnight with stirring. The imidazole 
remaining in solution was removed using 3000MWCO spin concentrators, the 
uncleaved material was removed by successive depletion on Ni-beads. The 
resulting eluent was purified using preparative-HPLC. The identity  of the purified 
protein 3 was confirmed by mass spectrometry; measured mass = 10403.3, 
predicted = 10403.1 Da. This protocol afforded ~0.5 mg of purified protein per L 
of intial bacterial culture. 
Ligation and desulphurization
Ligations were carried out by Sam Pollock in Tom Muir’s laboratory at 
Princeton University. 
Ligation of thioester peptides 1 (1 mM) and 2 (2.5 mM) to form polypeptide 4 
was carried out in ligation buffer (6M GuHCl, 0.2M phosphate pH 7.0, 50mM 
MPAA, 20mM TCEP) under argon at room temperature. The reaction was 
complete after 3hrs and the product purified by semi-preparative HPLC and 
characterized by ESI-MS (measured mass = 4944.9, predicted = 4944.8 Da). 
The hydrazine moeity in 4 was converted into a thioester as described (40). 
Briefly, polypeptide 4 was added at 2.5mM to sparged 6M GuHCl, 0.2M 
phosphate at pH 3.0, and cooled to -10deg C before adding 10mM NaNO2, 
letting sit 25min, and thioesterifying by addition of 150mM MPAA, 1mM 
polypeptide 3 and base up to pH 7.0. Following the addition of 30mM TCEP after 
1hr, and a complete reaction time of 6hr, full length histone protein 5 was purified 
by semi-preparative HPLC and characterized by ESI-MS (measured mass = 
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15316.7, predicted = 15316.9 Da). The final product 6 in which the cysteines at 
the ligation junctions were converted back to the native alanines was obtained 
through radical desulfurization according to established protocols (34). Briefly, 
protein 5 (0.3 mM) was dissolved in desulfurization buffer (6M GuHCl, 0.2M 
phosphate, 250mM TCEP, pH 7.0) and the reaction initiated through the addition 
of reduced glutathione (final concentration 30mM) and VA-061 (final 
concentration 16mM). The desulfurization solution was flushed with argon, 
wrapped in parafilm, and placed at 37° C overnight. Semisynthetic protein 6 was 
then purified out of the solution by semi-preparative HPLC purification. Fractions 
were analyzed by ESI-MS and lyophilized, yielding approximately 1mg of final 
product (measured mass = 15252.7, predicted = 15252.8 Da).
Histone purification and octamer formation
Wild-type, recombinant human histones were purified as described previously 
(Luger et al., 1999a; Ruthenburg et al., 2011). Mutant histones were generated 
by Quikchange mutagenesis (Stratagene). Briefly, His-histone constructs were 
transformed into BL21(DE3)PlysS cells (Invitrogen) and expressed as inclusion 
bodies.  After 4 hours of IPTG induction at a final concentration of 1mM, the cells 
were harvested and mechanically  lysed. The crude inclusion bodies were 
harvested and solubilised in buffer D500 (6.0M Guanidine•HCl, 500 mM NaCl, 50 
mM Tris•HCl pH 8, 10 mM 2-mercaptoethanol). The clarified denatured histones 
were incubated with Ni-NTA resin (Qiagen). After extensive washing histone 
protein was eluted and concentrated. 
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Histone octamers were prepared essentially  as previously described (Luger et 
al., 1999b; Ruthenburg et al., 2011). Briefly, stoichiometric quantities of each core 
histone were dissolved from lyophilized pellets in unfolding buffer (50mM 
Tris•HCl pH 8, 6 M Guanidine•HCl, 10mM 2-mercaptoethanol, 1mM EDTA), and 
dialyzed overnight against several buffer changes of refolding buffer (20 mM 
Tris•HCl pH 7.8, 2M NaCl, 1mM EDTA, 5 mM DTT).  1/50 mass equivalents of 
TEV and PreScission proteases were added after this overnight dialysis and 
permitted to cleave tagged histones for at least six hours.  The resultant crude 
octamer was then applied directly to an analytical Superdex 200 10/300 GL (GE 
Healthcare) resolved in refolding buffer. Peak fractions of octamer were pooled 
and concentrated in Amicon Ultra 10K N.M.C.O. centrifugal concentrators 
(Millipore).
Nucleosome assembly
DNA fragments corresponding to the 601 positioning sequence were 
prepared by EcoRV digestion of 32x153bp  tandem repeats cloned into pUC19 
(from Alex Ruthenburg). The 601 fragments were purified by plasmid backbone 
purification in 500 mM NaCl with 7.5% polyethylene glycol (PEG-6000) on ice for 
several hours. The soluble DNA fragments were further purified with several 
rounds of Phenol/Chloroform extraction and finally ethanol precipitated.
Gradient dyalisis was used to assemble mononucleosomes from octamers 
and 601 fragments. Equimolar amounts of purified octamers and DNA were 
mixed in refolding buffer. Starting in 1 volume of refolding buffer, a peristaltic 
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pump was used to add no salt buffer (10mM Tris pH 7.5, 1 mM EDTA) dropwise 
over 30 hours to a final volume of 10 volumes. Completed assemblies were 
cleared by centrifugation and visualized on a native 5% polyacrilamaide gel, 
stained with ethidium bromide.
Chromatin Transcription Assays
Transcription assays were performed by Dr. Xiangdong Lu in the laboratory of 
Robert Roeder at the Rockefeller University. Chromatin templates were 
assembled as described previously (An and Roeder, 2004; Ito et al., 1999). 
Transcription assays using activator p53 (20 ng) and coactivator p300 (10 ng) 
were conducted essentially  as described previously  (An et al., 2004; An and 
Roeder, 2004).
Peptide Pull-Down Assays
Biotinylated H3(34-52) peptides (or control peptides) were bound to High 
Capacity  Streptavidin Agarose resin (Thermo) and incubated for 4 hours at 4°C 
with either nuclear extract or purified proteins. After extensive washes with PPD 
wash buffer (50mM Tris pH 7.5, 300 mM NaCl, 0.1% NP-40), bound proteins 
were eluted with 100mM glycine pH 2.5 and run on SDS-PAGE gels. Proteins 
were visualized by silver staining or western blot. 
Recombinant GST-TBL1(228-600) and GST-TBLR1(165-550) were purified 
from E. coli Rosetta2. Cells were disrupted by high pressure on an Emulsiflex 
(Avestin) in PBS supplemented with 500 mM NaCl, 1 mM DTT and protease 
105
inhibitor cocktail tablets (Sigma). Cleared lysates were incubated with 
Glutathione-Sepharose 4B resin (GE Healthcare). After extensive washes bound 
proteins were eluted with 20 mM reduced glutathione. Around 100 μg of protein 
was used in each pull-down. In vitro transcription/translation of the same 
domains was carried out using TNT Coupled Reticulocyte Lysate (Promega). 1 
μg of template DNA was incubated for 90 minutes at 30°C with 25 μl of TNT 
Rabbit Reticulocyte Lysate supplemented with amino acid mix and 20 μCi 
[35S]methionine. At the end of the reaction, equal volumes were added to pull-
down tubes.
HDAC Assays
Reagents were from Fluorescent HDAC Assay kit (Active Motif). 0.5 μg of 
affinity  purified N-CoR complex were incubated with HDAC Substrate in HDAC 
Assay Buffer and increasing concentrations of histone peptides for 1 hour at 
37°C in black 96-well plates. The reactions were stopped by adding HDAC Assay 
Developing Solution. After a 15 minutes incubation at room temperature, 
fluorescence was measured with a fluorescent plate reader Synergy H4 (Biotek) 
with excitation wavelength at 360 nm and emission wavelength at 460 nm.
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